Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 by Andrew, Kemp
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in :
The Lancet
                             
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa26231
_____________________________________________________________
 
Paper:
Andrew, H. (2014).  Global, regional, and national levels and causes of maternal mortality during 1990–2013: a
systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 384(9947), 980-1004.
http://dx.doi.org/10.1016/S0140-6736(14)60696-6
 
 
 
 
 
 
 
 
_____________________________________________________________
  
This article is brought to you by Swansea University. Any person downloading material is agreeing to abide by the
terms of the repository licence. Authors are personally responsible for adhering to publisher restrictions or conditions.
When uploading content they are required to comply with their publisher agreement and the SHERPA RoMEO
database to judge whether or not it is copyright safe to add this version of the paper to this repository. 
http://www.swansea.ac.uk/iss/researchsupport/cronfa-support/ 
 Articles
980 www.thelancet.com   Vol 384   September 13, 2014
Global, regional, and national levels and causes of maternal 
mortality during 1990–2013: a systematic analysis for the 
Global Burden of Disease Study 2013
Summary
Background The ﬁ fth Millennium Development Goal (MDG 5) established the goal of a 75% reduction in the maternal 
mortality ratio (MMR; number of maternal deaths per 100 000 livebirths) between 1990 and 2015. We aimed to 
measure levels and track trends in maternal mortality, the key causes contributing to maternal death, and timing of 
maternal death with respect to delivery.
Methods We used robust statistical methods including the Cause of Death Ensemble model (CODEm) to analyse a 
database of data for 7065 site-years and estimate the number of maternal deaths from all causes in 188 countries 
between 1990 and 2013. We estimated the number of pregnancy-related deaths caused by HIV on the basis of a 
systematic review of the relative risk of dying during pregnancy for HIV-positive women compared with HIV-negative 
Nicholas J Kassebaum*, Amelia Bertozzi-Villa, Megan S Coggeshall, Katya A Shackelford, Caitlyn Steiner, Kyle R Heuton, Diego Gonzalez-Medina, Ryan Barber, Chantal Huynh, 
Daniel Dicker, Tara Templin, Timothy M Wolock, Ayse Abbasoglu Ozgoren†, Foad Abd-Allah†, Semaw Ferede Abera†, Ibrahim Abubakar†, Tom Achoki†, Ademola Adelekan†, 
Zanﬁ na Ademi†, Arsène Kouablan Adou†, José C Adsuar†, Emilie E Agardh†, Dickens Akena†, Deena Alasfoor†, Zewdie Aderaw Alemu†, Rafael Alfonso-Cristancho†, 
Samia Alhabib†, Raghib Ali†, Mazin J Al Kahbouri†, François Alla†, Peter J Allen†, Mohammad A AlMazroa†, Ubai Alsharif†, Elena Alvarez†, Nelson Alvis-Guzmán†, 
Adansi A Amankwaa†, Azmeraw T Amare†, Hassan Amini†, Walid Ammar†, Carl A T Antonio†, Palwasha Anwari†, Johan Ärnlöv†, Valentina S Arsic Arsenijevic†, Ali Artaman†, 
Majed Masoud Asad†, Rana J Asghar†, Reza Assadi†, Lydia S Atkins†, Alaa Badawi†, Kalpana Balakrishnan†, Arindam Basu†, Sanjay Basu†, Justin Beardsley†, Neeraj Bedi†, 
Tolesa Bekele†, Michelle L Bell†, Eduardo Bernabe†, Tariku J Beyene†, Zulﬁ qar Bhutta†, Aref Bin Abdulhak†, Jed D Blore†, Berrak Bora Basara†, Dipan Bose†, Nicholas Breitborde†, 
Rosario Cárdenas†, Carlos A Castañeda-Orjuela†, Ruben Estanislao Castro†, Ferrán Catalá-López†, Alanur Cavlin†, Jung-Chen Chang†, Xuan Che†, Costas A Christophi†, 
Sumeet S Chugh†, Massimo Cirillo†, Samantha M Colquhoun†, Leslie Trumbull Cooper†, Cyrus Cooper†, Iuri da Costa Leite†, Lalit Dandona†, Rakhi Dandona†, Adrian Davis†, 
Anand Dayama†, Louisa Degenhardt†, Diego De Leo†, Borja del Pozo-Cruz†, Kebede Deribe†, Muluken Dessalegn†, Gabrielle A deVeber†, Samath D Dharmaratne†, Uğur Dilmen†, 
Eric L Ding†, Rob E Dorrington†, Tim R Driscoll†, Sergei Petrovich Ermakov†, Alireza Esteghamati†, Emerito Jose A Faraon†, Farshad Farzadfar†, Manuela Mendonca Felicio†, 
Seyed-Mohammad Fereshtehnejad†, Graça Maria Ferreira de Lima†, Mohammad H Forouzanfar†, Elisabeth B França†, Lynne Gaﬃ  kin†, Ketevan Gambashidze†, 
Fortuné Gbètoho Gankpé†, Ana C Garcia†, Johanna M Geleijnse†, Katherine B Gibney†, Maurice Giroud†, Elizabeth L Glaser†, Ketevan Goginashvili†, Philimon Gona†, 
Dinorah González-Castell†, Atsushi Goto†, Hebe N Gouda†, Harish Chander Gugnani†, Rahul Gupta†, Rajeev Gupta†, Nima Hafezi-Nejad†, Randah Ribhi Hamadeh†, 
Mouhanad Hammami†, Graeme J Hankey†, Hilda L Harb†, Rasmus Havmoeller†, Simon I Hay†, Ileana B Heredia Pi†, Hans W Hoek†, H Dean Hosgood†, Damian G Hoy†, 
Abdullatif Husseini†, Bulat T Idrisov†, Kaire Innos†, Manami Inoue†, Kathryn H Jacobsen†, Eiman Jahangir†, Sun Ha Jee†, Paul N Jensen†, Vivekanand Jha†, Guohong Jiang†, 
Jost B Jonas†, Knud Juel†, Edmond Kato Kabagambe†, Haidong Kan†, Nadim E Karam†, André Karch†, Corine Kakizi Karema†, Anil Kaul†, Norito Kawakami†, 
Konstantin Kazanjan†, Dhruv S Kazi†, Andrew H Kemp†, Andre Pascal Kengne†, Maia Kereselidze†, Yousef Saleh Khader†, Shams Eldin Ali Hassan Khalifa†, Ejaz Ahmed Khan†, 
Young-Ho Khang†, Luke Knibbs†, Yoshihiro Kokubo†, Soewarta Kosen†, Barthelemy Kuate Defo†, Chanda Kulkarni†, Veena S Kulkarni†, G Anil Kumar†, Kaushalendra Kumar†, 
Ravi B Kumar†, Gene Kwan†, Taavi Lai†, Ratilal Lalloo†, Hilton Lam†, Van C Lansingh†, Anders Larsson†, Jong-Tae Lee†, James Leigh†, Mall Leinsalu†, Ricky Leung†, Xiaohong Li†, 
Yichong Li†, Yongmei Li†, Juan Liang†, Xiaofeng Liang†, Stephen S Lim†, Hsien-Ho Lin†, Steven E Lipshultz†, Shiwei Liu†, Yang Liu†, Belinda K Lloyd†, Stephanie J London†, 
Paulo A Lotufo†, Jixiang Ma†, Stefan Ma†, Vasco Manuel Pedro Machado†, Nana Kwaku Mainoo†, Marek Majdan†, Christopher Chabila Mapoma†, Wagner Marcenes†, 
Melvin Barrientos Marzan†, Amanda J Mason-Jones†, Man Mohan Mehndiratta†, Fabiola Mejia-Rodriguez†, Ziad A Memish†, Walter Mendoza†, Ted R Miller†, Edward J Mills†, 
Ali H Mokdad†, Glen Liddell Mola†, Lorenzo Monasta†, Jonathan de la Cruz Monis†, Julio Cesar Montañez Hernandez†, Ami R Moore†, Maziar Moradi-Lakeh†,Rintaro Mori†, 
Ulrich O Mueller†, Mitsuru Mukaigawara†, Aliya Naheed†, Kovin S Naidoo†, Devina Nand†, Vinay Nangia†, Denis Nash†, Chakib Nejjari†, Robert G Nelson†, 
Sudan Prasad Neupane†, Charles R Newton†, Marie Ng†, Mark J Nieuwenhuijsen†, Muhammad Imran Nisar†, Sandra Nolte†, Ole F Norheim†, Luke Nyakarahuka†, 
In-Hwan Oh†, Takayoshi Ohkubo†, Bolajoko O Olusanya†, Saad B Omer†, John Nelson Opio†, Orish Ebere Orisakwe†, Jeyaraj D Pandian†, Christina Papachristou†, 
Jae-Hyun Park†, Angel J Paternina Caicedo†, Scott B Patten†, Vinod K Paul†, Boris Igor Pavlin†, Neil Pearce†, David M Pereira†, Konrad Pesudovs†, Max Petzold†, Dan Poenaru†, 
Guilherme V Polanczyk†, Suzanne Polinder†, Dan Pope†, Farshad Pourmalek†, Dima Qato†, D Alex Quistberg†, Anwar Rafay†, Kazem Rahimi†, Vafa Rahimi-Movaghar†, 
Sajjad ur Rahman†, Murugesan Raju†, Saleem M Rana†, Amany Refaat†, Luca Ronfani†, Nobhojit Roy†, Tania Georgina Sánchez Pimienta†, Mohammad Ali Sahraian†, 
Joshua A Salomon†, Uchechukwu Sampson†, Itamar S Santos†, Monika Sawhney†, Felix Sayinzoga†, Ione J C Schneider†, Austin Schumacher†, David C Schwebel†, Soraya Seedat†, 
Sadaf G Sepanlou†, Edson E Servan-Mori†, Marina Shakh-Nazarova†, Sara Sheikhbahaei†, Kenji Shibuya†, Hwashin Hyun Shin†, Ivy Shiue†, Inga Dora Sigfusdottir†, 
Donald H Silberberg†, Andrea P Silva†, Jasvinder A Singh†, Vegard Skirbekk†, Karen Sliwa†, Sergey S Soshnikov†, Luciano A Sposato†, Chandrashekhar T Sreeramareddy†, 
Konstantinos Stroumpoulis†, Lela Sturua†, Bryan L Sykes†, Karen M Tabb†, Roberto Tchio Talongwa†, Feng Tan†, Carolina Maria Teixeira†, Eric Yeboah Tenkorang†, 
Abdullah Sulieman Terkawi†, Andrew L Thorne-Lyman†, David L Tirschwell†, Jeﬀ rey A Towbin†, Bach X Tran†, Miltiadis Tsilimbaris†, Uche S Uchendu†, Kingsley N Ukwaja†, 
Eduardo A Undurraga†, Selen Begüm Uzun†, Andrew J Vallely†, Coen H van Gool†, Tommi J Vasankari†, Monica S Vavilala†, N Venketasubramanian†, Salvador Villalpando†, 
Francesco S Violante†, Vasiliy Victorovich Vlassov†, Theo Vos†, Stephen Waller†, Haidong Wang†, Linhong Wang†, XiaoRong Wang†, Yanping Wang†, Scott Weichenthal†, 
Elisabete Weiderpass†, Robert G Weintraub†, Ronny Westerman†, James D Wilkinson†, Solomon Meseret Woldeyohannes†, John Q Wong†, Muluemebet Abera Wordofa†, 
Gelin Xu†, Yang C Yang†, Yuichiro Yano†, Gokalp Kadri Yentur†, Paul Yip†, Naohiro Yonemoto†, Seok-Jun Yoon†, Mustafa Z Younis†, Chuanhua Yu†, Kim Yun Jin†, 
Maysaa El Sayed Zaki†, Yong Zhao†, Yingfeng Zheng†, Maigeng Zhou†, Jun Zhu†, Xiao Nong Zou†, Alan D Lopez‡, Mohsen Naghavi‡, Christopher J L Murray‡, Rafael Lozano‡
Lancet 2014; 384: 980–1004 
Published Online
May 2, 2014
http://dx.doi.org/10.1016/
S0140-6736(14)60696-6
See Comment page 933
This online publication has 
been corrected. The corrected 
version ﬁ rst appeared at 
thelancet.com on Sept 12, 2014
Articles
www.thelancet.com   Vol 384   September 13, 2014 981
*Corresponding author
†Authors listed alphabetically
‡Joint senior authors
Institute for Health Metrics and 
Evaluation (N J Kassebaum MD,  
A Bertozzi-Villa BA, 
M S Coggeshall BA, 
K A Shackelford BA, C Steiner MPH, 
K R Heuton BS, 
D Gonzalez-Medina BA, 
R Barber BS, C Huynh BA, 
D Dicker BS, T Templin BA, 
T M Wolock BA, 
Prof L Dandona PhD, 
M H Forouzanfar MD, S S Lim PhD, 
Prof A H Mokdad PhD, 
M Moradi-Lakeh MD, M Ng MD, 
A Schumacher BS, Prof T Vos PhD, 
H Wang PhD, M Naghavi PhD, 
Prof C J L Murray PhD, 
Prof R Lozano MD), Department 
of Neurology (D L Tirschwell MD), 
Pediatric Anesthesiology and 
Pain Medicine, Seattle Children’s 
Hospital, School of Medicine 
(N J Kassebaum), University of 
Washington, Seattle, WA, USA 
(R Alfonso-Cristancho PhD, 
P N Jensen MPH, 
D A Quistberg PhD, 
M S Vavilala MD); Hacettepe 
University Institute of 
Population Studies, Ankara, 
Turkey (A Abbasoglu Ozgoren MA, 
A Cavlin PhD); Faculty of 
Medicine, Cairo University, Cairo, 
Egypt (Prof F Abd-Allah MD); 
School of Public Health, College 
of Health Sciences, Mekelle 
University, Mekelle, Tigray, 
Ethiopia (S F Abera MSc); 
University College London, 
London, UK 
(Prof I Abubakar PhD); Ministry of 
Health, Gaborone, Botswana 
(T Achoki PhD); Public Health 
Promotion Alliance, Osogbp, 
Nigeria (A Adelekan PhD); Centre 
for International Child Health 
(S M Colquhoun PhD), University 
of Melbourne, Melbourne, VIC, 
Australia (Z Ademi PhD, 
J D Blore PhD, R G Weintraub MB, 
Prof A D Lopez PhD); Association 
Ivoirienne Pour Le Bien Etre 
Familial, Abidjan, Côte d’Ivoire 
(A K Adou MD); University of 
Extremadura, Cáceres, Spain 
(Prof J C Adsuar PhD); Institution 
of Public Health Sciences, 
Stockholm, Sweden 
(E E Agardh PhD); Makerere 
University, Kampala, Uganda 
(D Akena PhD, 
L Nyakarahuka MPH); Ministry of 
Health, Muscat, Oman 
(D Alasfoor MSc, 
M J Al Kahbouri PhD); Debre 
Markos University, Debre 
Markos, Amhara, Ethiopia
women. We also estimated the fraction of these deaths aggravated by pregnancy on the basis of a systematic review. 
To estimate the numbers of maternal deaths due to nine diﬀ erent causes, we identiﬁ ed 61 sources from a systematic 
review and 943 site-years of vital registration data. We also did a systematic review of reports about the timing of 
maternal death, identifying 142 sources to use in our analysis. We developed estimates for each country for 1990–2013 
using Bayesian meta-regression. We estimated 95% uncertainty intervals (UIs) for all values.
Findings 292 982 (95% UI 261 017–327 792) maternal deaths occurred in 2013, compared with 376 034 (343 483–407 574) 
in 1990. The global annual rate of change in the MMR was –0·3% (–1·1 to 0·6) from 1990 to 2003, and –2·7% 
(–3·9 to –1·5) from 2003 to 2013, with evidence of continued acceleration. MMRs reduced consistently in south, east, 
and southeast Asia between 1990 and 2013, but maternal deaths increased in much of sub-Saharan Africa during the 
1990s. 2070 (1290–2866) maternal deaths were related to HIV in 2013, 0·4% (0·2–0·6) of the global total. MMR was 
highest in the oldest age groups in both 1990 and 2013. In 2013, most deaths occurred intrapartum or postpartum. 
Causes varied by region and between 1990 and 2013. We recorded substantial variation in the MMR by country in 
2013, from 956·8 (685·1–1262·8) in South Sudan to 2·4 (1·6–3·6) in Iceland.
Interpretation Global rates of change suggest that only 16 countries will achieve the MDG 5 target by 2015. Accelerated 
reductions since the Millennium Declaration in 2000 coincide with increased development assistance for maternal, 
newborn, and child health. Setting of targets and associated interventions for after 2015 will need careful consideration 
of regions that are making slow progress, such as west and central Africa.
Funding Bill & Melinda Gates Foundation.
Introduction
Since the 1980s, the global health community has 
focused on reducing maternal mortality through a 
sequence of initiatives, beginning with the Safe 
Motherhood movement in 1987, to the creation of the 
Partnership for Maternal, Newborn and Child Health in 
2005.1,2 The priority accorded to reductions in maternal 
mortality is shown by its choice as one of the eight 
Millennium Development Goals (MDGs). Despite these 
eﬀ orts and visibility, there was broad concern that little 
or no progress was being made, which prompted 
intensiﬁ ed eﬀ orts by the UN Secretary General through 
the launch of Every Woman Every Child in 2010, and the 
subsequent creation of the Commission on Information 
and Accountability for Women’s and Children’s Health.2,3 
In 2010, a comprehensive assessment of global trends in 
maternal mortality suggested that the maternal 
mortality ratio (MMR; number of maternal deaths per 
100 000 livebirths) had decreased by 1·3% per year since 
1990.4 Subsequent revisions of the historical estimates 
have shown even larger worldwide rates of change, from 
–1·9% to –3·1% per year.5,6 This evidence collectively 
suggests that, although concerns about the rate of change 
of maternal mortality might have been too pessimistic, 
there is substantial uncertainty about how rapid the 
decrease has been and about the actual numbers of 
deaths in several large populations. If policy debates 
about acceleration of maternal mortality reductions are 
to be usefully informed, goals established, and targets set 
for reproductive health, up-to-date monitoring of the 
levels and trends in maternal mortality is essential.7
Compared with child mortality, maternal mortality has 
been more diﬃ  cult to track over time at the national 
level.8 Several major challenges have to be addressed in 
any measurement eﬀ ort: misclassiﬁ cation of maternal 
deaths to other causes in countries with complete vital 
registration and medical certiﬁ cation of causes of death; 
substantial sampling error in measurements that depend 
on survey recall because few maternal deaths are 
reported; large non-sampling error in survey and census 
measurements as demonstrated in settings with repeated 
overlapping measurements; variation in the demographic 
assessment of reproductive-age mortality from all causes, 
particularly in the 1990s; and the need for models to 
synthesise data from several studies or generate 
estimates when data are sparse.9–11 The substantial 
diﬀ erences between global modelling eﬀ orts, which are 
at times substantial, emphasise the inﬂ uence of each of 
the analytical steps used to estimate maternal mortality.12 
Political attention to how countries are progressing 
towards MDG 5 targets is intensifying.1,13 Donors, global 
health partners, and national programme managers are 
understandably frustrated by the wide uncertainty 
intervals and the variability of estimates from diﬀ erent 
analysts.8
Here, we use the systematic approach of the Global 
Burden of Diseases, Injuries, and Risk Factors Study 
2013 (GBD 2013) to measure levels and track trends in 
maternal mortality, the key causes contributing to 
maternal death, and the timing of maternal deaths. In 
GBD 2013, with application of rigorous statistical 
methods to critically appraise and synthesise data from 
diﬀ erent sources to estimate levels and causes of death 
in each age and sex group, a consistent and holistic 
approach to the challenges of maternal mortality 
measurement is used that enables comparisons across 
time, country, and other important causes of death in 
women of reproductive age. Algorithms for cause of 
death reclassiﬁ cation are applied consistently across all 
causes and modelling strategies use methods with clearly 
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quantiﬁ ed out-of-sample predictive validity.14 On the basis 
of recent trends in MMR, we also project an MMR 
scenario for 2030 to inform policy debates by identifying 
which countries are in greatest need of intensiﬁ ed focus.
Methods
Maternal mortality 1990–2013
Data
We used the GBD 2013 cause of death database, which 
extends from 1980 to 2013, to estimate maternal mortality. 
Although we report estimates for the MDG period 
1990–2013, data for 1980–90 are included in the analysis 
to improve the robustness of the time trend estimation. 
Naghavi and colleagues15 provide substantial detail about 
the inclusion criteria and data processing of studies 
across all causes. Brieﬂ y, building on previous analyses, 
we identiﬁ ed data from 180 of 188 GBD countries, 
including 4877 site-years of vital registration data, 
1213 site-years of sibling histories from Demographic 
and Health Surveys (DHS) and Reproductive Health 
Surveys (RHS) providing information about the 
pregnancy-related fraction of reproductive-age deaths, 
73 site-years of censuses, 626 site-years of maternal 
mortality surveillance, and 267 site-years of verbal 
autopsy analyses covering women of reproductive age.4,5,16 
We identiﬁ ed the above data sources through a systematic 
review (appendix), from analyses by Lozano and 
colleagues5 and GBD 2010 analyses,16  searches of 
Ministry of Health websites, and a search of the Global 
Health Data Exchange.
There has been much debate about which deaths of 
women of reproductive age should be included as 
maternal deaths. To be classiﬁ ed as maternal, pregnancy 
needs to be a causal factor in death. It can either have a 
direct eﬀ ect (complications of the pregnancy or 
childbirth, or postpartum complications) or indirect 
eﬀ ect (exacerbation of a pre-existing condition). 
Therefore, accidental or incidental deaths in which 
pregnancy had no causal role are not classiﬁ ed as 
maternal deaths. Deﬁ nitions for national use based on 
the International Classiﬁ cation of Diseases (ICD) have 
diﬀ ered from other recommendations for international 
comparisons of the MMR. All deﬁ nitions include direct 
and indirect causes during pregnancy and within 6 weeks 
of the termination of pregnancy (ﬁ gure 1). ICD-10 
deﬁ nitions also include late maternal deaths between 
6 weeks and 1 year after termination.6,17 For some causes, 
such as suicide, there is national variation in whether 
they are coded as incidental or indirect.18,19 MDG guidance 
for cross-country comparisons of MMR recommends 
that all HIV-related deaths during pregnancy or within 
6 weeks should be included in the MMR,20 but the UN 
group estimating maternal mortality uses only 50% of 
these deaths in their estimation.6,20 Conceptually, only the 
fraction of deaths aggravated by pregnancy should be 
included, because that is the deﬁ nition of an indirect 
cause of maternal mortality.
We included direct and indirect deaths during 
pregnancy and within 6 weeks of delivery, plus late 
maternal deaths up to 1 year after delivery and the 
fraction of HIV-related deaths aggravated by pregnancy. 
Late maternal deaths were not coded in ICD-9 so data are 
only available for ICD-10 (ie, from 1994). Additionally, 
because maternal deaths in the age group 10–14 years 
have been consistently reported in our data sources, we 
have estimated the number of maternal deaths in this 
age group but have not included them in the computation 
of the MMR because no standard estimates of birth rates 
are available for this group.
In vital registration and verbal autopsy data, maternal 
deaths are often misclassiﬁ ed as deaths attributable to 
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other underlying causes. We reassigned deaths assigned to 
causes that are unlikely to be underlying causes of death 
with standardised algorithms.14 The causes of death that 
are partly reassigned to maternal causes are shown in the 
appendix.15 We reanalysed DHS and RHS microdata for 
sibling deaths that were related to pregnancy by year using 
Gakidou-King weights to deal with potential survivor bias.21 
We used a Bayesian noise reduction algorithm to 
preprocess data to avoid the issue of large stochastic 
ﬂ uctuations and zero counts leading to distorted time 
trends (appendix). When diﬀ erent DHS surveys provided 
data for reproductive-age deaths and the number that were 
related to pregnancy for the same year, we pooled results 
for that year to reduce stochastic measurement error. 
Additionally, for some vital registration data, no maternal 
deaths are reported in speciﬁ c age group or for a speciﬁ c 
period. Noise reduction algorithms again help to reduce 
upward bias because all zero counts would otherwise be 
dropped from natural logarithm death rate and logit cause 
fraction models.  Data were unavailable for only eight 
countries, for which we relied entirely on model predictions 
for maternal mortality estimates.
HIV-related mortality
Because of the rapid increase in reproductive-age 
mortality due to the HIV epidemic in eastern and 
southern Africa, disentangling the fraction of HIV deaths 
during pregnancy that are incidental (ie, not related to 
pregnancy) from those aggravated by pregnancy (ie, 
maternal deaths) is important. Assessment of HIV-
related mortality during pregnancy has two steps: 
estimation of the fraction of deaths during pregnancy or 
within 6 weeks of delivery that are related to HIV, and 
estimation of the fraction of these HIV-related deaths 
that are aggravated by pregnancy. For the ﬁ rst step, we 
updated Calvert and Ronsmans’ systematic review22 
(appendix). We identiﬁ ed one new study, giving a total 
of 21 for which we could examine mortality risk during 
pregnancy for HIV-positive versus HIV-negative 
women.23–43 We excluded data from non-representative 
populations, from sources that did not include 
postpartum deaths, and any deaths more than 1 year after 
delivery. Most studies did not specify antiretroviral 
therapy (ART) status. We undertook a DerSimonian-
Laird meta-analysis of the relative risk (RR) of death. 
Studies were heterogeneous and the pooled RR was 6·40 
(ﬁ gure 2). We identiﬁ ed no clear geographical pattern to 
explain why some studies are signiﬁ cantly above or 
below the pooled estimate, nor any clear relation with 
other study attributes, meaning that we had an 
insuﬃ  cient basis for further weighting of input studies.
We used the RR and estimated HIV prevalence in 
pregnant women (based on the UNAIDS Spectrum 
model) to estimate the population attributable fraction of 
pregnancy-related deaths that are related to HIV. To 
estimate the fraction of HIV-related deaths aggravated by 
pregnancy, we did another systematic review (appendix). 
We could identify only two studies to inform this fraction, 
with a pooled RR of 1·13 (95% UI 0·73–1·77),44,45 
corresponding to a frequency of all HIV-related deaths 
during pregnancy that should be counted as maternal 
deaths of 11·5% (0–43·5). Several additional studies did 
not show increased risk of HIV-related mortality during 
pregnancy, but were excluded because stratiﬁ cation of 
the study population on the basis of stage of HIV or ART 
status was not completed.
Modelling
Following Lozano and colleagues’ methods,5 we used the 
Cause of Death Ensemble model (CODEm) to model 
maternal mortality by age (appendix). With CODEm, 
many models are developed and their performance is 
assessed objectively.46 We selected nine covariates for 
CODEm to test on the basis of previously reported 
associations that also have a plausible causal association 
with maternal mortality: age-speciﬁ c fertility rate, total 
fertility rate, age-standardised HIV death rate for female 
individuals aged 15–49 years, neonatal death rate, lag-
distributed gross domestic product (GDP) per person 
(GDP per person computed with a triangle lag that 
weights more recent years more heavily), proportion of 
deliveries occurring in facilities, proportion of deliveries 
overseen by skilled birth attendants, coverage of four 
visits of antenatal care, and malnutrition in children 
younger than 5 years (<2 SD below mean weight for age; 
used as a proxy for adult nutritional status; appendix).
We divided covariates into three groups to enable 
computation. Level 1 covariates had the strongest likely 
relation with maternal mortality; covariates in levels 2 
and 3 had weaker likely relations. CODEm tests all 
combinations of level 1 covariates and nearly every 
combination of level 2 and level 3 covariates using four 
families of models: mixed eﬀ ects linear regression of the 
logit-transformed cause-speciﬁ c mortality fraction, 
spatial-temporal Gaussian Process Regression (ST-GPR) 
of the logit-transformed cause-speciﬁ c mortality rate, 
mixed eﬀ ects linear regression of the natural log of the 
maternal death rate, and ST-GPR of the natural log of 
the maternal death rate.46 30% of the data were not 
included in the models. Models were retained when the 
beta for each covariate was signiﬁ cant and in the 
direction allowed by previous evidence. The performance 
of each retained model was then assessed with half the 
held-out data in terms of the root-mean squared error of 
the prediction of the model compared with the data held 
out, and the root-mean squared error of the trend in the 
model compared with the trend in the data. Ensemble 
models were developed on the basis of the rankings of 
individual models and the performance of diﬀ erent 
ensembles assessed in the second half of the data held 
out of the regression (appendix). The best performing 
ensemble was selected and reﬁ tted to all data.
One of the strengths of the GBD is that all causes 
are simultaneously estimated. Estimates of every 
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cause-speciﬁ c death rate are necessary to sum to all-cause 
mortality using the CoDCorrect algorithm.16 To ensure 
they do sum to all-cause mortality, at the level of each 
draw from the posterior distribution of each cause of 
death for a speciﬁ c country, year, and age group, the sum 
of all causes was rescaled to equal a draw taken from the 
uncertainty distribution of all-cause mortality for that 
country, year, and age group.
Causes of maternal death
We disaggregated maternal deaths into nine causes: 
maternal haemorrhage, maternal sepsis and other 
pregnancy-related infections, hypertensive disorders of 
pregnancy, obstructed labour, abortion, other direct 
maternal disorders, indirect maternal disorders, HIV, 
and late maternal deaths. To estimate the diﬀ erent 
causes of maternal death, we completed a systematic 
review (appendix) to identify data to inform which 
proportion of total maternal deaths is due to each cause. 
Additionally, we incorporated all vital registration and 
sample registration data that provided ICD-coded detail 
for maternal causes (appendix). We identiﬁ ed 61 studies 
and, after processing, included 943 site-years of vital 
registration, sample registration, and maternal 
mortality surveillance data.
We modelled the proportion of maternal deaths for all 
causes except HIV using DisMod-MR (version 2.0), 
which is a Bayesian meta-regression tool developed for 
the GBD (appendix). This version of DisMod-MR allows 
for two types of ﬁ xed eﬀ ects (study attributes and country 
covariates) and includes nested random eﬀ ects for super-
region, region, and country. A key advantage of DisMod-
MR is that it can handle data reported for any age interval. 
Predictions from DisMod-MR for each group divided by 
country, year, and age are based on the country covariates, 
reference values of the study level covariates, and 
hierarchical random eﬀ ects. Point estimates with 
uncertainty were produced for six discrete points: 1990, 
1995, 2000, 2005, 2010, and 2013. Each cause was 
modelled independently. Predicted cause fractions for 
each group were rescaled to equal 100% of the deaths not 
related to HIV. The rescaled cause fractions were then 
multiplied by the number of maternal deaths in each 
group (divided by country, year, and age) to obtain the 
number of deaths for each maternal cause, a sum to 
which the HIV deaths were added. The ﬁ nal result 
includes cause fraction and number of maternal deaths 
due to each cause, country, age group, and year.
Timing of maternal deaths
An important issue for planning of interventions is an 
understanding of the timing of maternal deaths with 
respect to labour and delivery.47 We completed a 
systematic review to identify studies of the timing of 
maternal deaths (appendix). We identiﬁ ed 142 studies 
and used vital registration, sample registration, and 
surveillance data for late maternal death. Many studies 
combined the ﬁ rst 24 h postpartum (immediate or early 
postpartum) with the intrapartum period, because events 
of the immediate postpartum period are clinically related 
to events occurring during labour and delivery. Therefore, 
we also combined intrapartum and immediate 
postpartum periods. We followed this format to construct 
a dataset that included four diﬀ erent time windows: 
deaths occurring antepartum (before onset of labour), 
deaths occurring intrapartum or during the immediate 
postpartum period (up to 24 h after delivery), deaths 
occurring during the subacute and delayed postpartum 
periods (24 h to 42 days after delivery),47 and late maternal 
deaths (43 days to 1 year after delivery). We modelled the 
proportion of maternal deaths in each of the four periods 
with DisMod-MR (version 2.0). The predicted proportions 
were scaled to 100% for each group.
2030 scenario and rate-of-change calculations
We developed a straightforward forecast scenario for the 
MMR for every country in 2030 by using the estimated 
Figure 3: Global maternal deaths (A) and annualised rate of change in maternal mortality ratio (B), 1990–2013
Shaded areas show 95% uncertainty intervals.
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Maternal mortality ratio (per 100 000 livebirths) Number of maternal deaths Annualised rate of change in maternal 
mortality ratio (%)
1990 2003 2013 1990 2003 2013 1990–2003 2003–13 1990–2013
Worldwide 283·2 
(258·6 to 306·9)
273·4 
(251·1 to 296·6)
209·1 
(186·3 to 233·9)
376 034 
(343 483 to 407 574)
361 706 
(332 230 to 392 393)
292 982 
(261 017 to 327 792)
–0·3% 
(–1·1 to 0·6)
–2·7% 
(–3·9 to –1·5)
–1·3% 
(–1·9 to –0·8)
Developed 
countries
24·5 
(23·0 to 26·1)
16·0
(14·9 to 17·0)
12·1 
(10·4 to 13·7)
3827
(3596 to 4076)
2341
(2178 to 2490)
1811
(1560 to 2053)
–3·3% 
(–3·8 to –2·8)
–2·9% 
(–4·2 to –1·5)
–3·1% 
(–3·7 to –2·5)
Developing 
countries
317·6 
(289·9 to 344·5)
305·4 
(280·3 to 331·5)
232·8 
(207·3 to 260·6)
372 207
(339 780 to 403 753)
359 365
(329 892 to 390 100)
291 171
(259 299 to 325 923)
–0·3% 
(–1·2 to 0·6)
–2·7% 
(–4·0 to –1·5)
–1·4% 
(–1·9 to –0·8)
High-income 
Asia Paciﬁ c
16·4 
(14·4 to 18·4)
10·3
(8·9 to 12·1)
7·9
(6·3 to 9·9)
325
(285 to 363)
173
(150 to 204)
128
(103 to 162)
–3·6% 
(–4·9 to –2·1)
–2·7% 
(–4·6 to –0·6)
–3·2% 
(–4·2 to –2·0)
Brunei 27·2 
(18·9 to 39·0)
18·6 
(13·8 to 24·6)
14·6
(9·8 to 21·1)
2
(1 to 3)
1
(1 to 2)
1
(1 to 1)
–2·9% 
(–6·3 to 0·4)
–2·5% 
(–6·7 to 1·9)
–2·7% 
(–5·0 to –0·4)
Japan 14·2 
(12·2 to 16·2)
8·2
(6·8 to 9·8)
6·1
(4·7 to 7·9)
171
(148 to 195)
94
(78 to 113)
66
(51 to 86)
–4·3% 
(–5·7 to –2·6)
–2·9% 
(–5·7 to –0·2)
–3·7% 
(–4·9 to –2·3)
Singapore 10·4
(8·5 to 12·8)
8·8
(7·2 to 10·8)
4·5
(3·4 to 5·8)
6
(5 to 7)
4
(3 to 5)
2
(2 to 3)
–1·2% 
(–3·3 to 0·7)
–6·8% 
(–9·4 to –3·9)
–3·6% 
(–5·3 to –2·2)
South Korea 20·7 
(17·5 to 23·9)
15·4
(12·8 to 19·0)
12·0
(8·7 to 16·7)
145
(123 to 168)
74
(61 to 91)
58
(42 to 81)
–2·3% 
(–4·3 to –0·1)
–2·6% 
(–5·7 to 0·4)
–2·4% 
(–3·9 to –0·7)
Central Asia 61·7 
(58·0 to 65·6)
45·1 
(41·6 to 49·0)
31·5 
(27·0 to 37·0)
1188
(1119 to 1265)
724
(668 to 786)
569
(487 to 668)
–2·4% 
(–3·2 to –1·7)
–3·6% 
(–5·4 to –1·9)
–2·9% 
(–3·6 to –2·2)
Armenia 43·3 
(36·0 to 51·3)
35·2
(29·1 to 42·5)
18·3 
(13·9 to 23·4)
32
(26 to 38)
15
(13 to 19)
8
(6 to 10)
–1·6% 
(–3·5 to 0·4)
–6·6% 
(–9·7 to –3·6)
–3·8% 
(–5·1 to –2·4)
Azerbaijan 42·4 
(36·6 to 49·0)
37·3
(31·4 to 44·2)
23·9 
(17·1 to 33·9)
84
(72 to 97)
57
(48 to 67)
40
(29 to 57)
–1·0% 
(–2·8 to 0·8)
–4·6% 
(–8·2 to –0·4)
–2·5% 
(–4·0 to –1·0)
Georgia 42·0 
(35·4 to 49·8)
31·7
(26·3 to 38·0)
31·1 
(24·7 to 38·8)
37
(32 to 44)
19
(16 to 23)
18
(14 to 23)
–2·2% 
(–4·1 to –0·2)
–0·2% 
(–3·0 to 2·6)
–1·3% 
(–2·4 to –0·1)
Kazakhstan 70·9 
(62·1 to 80·0)
36·0
(31·0 to 41·7)
27·0 
(19·5 to 35·4)
247
(216 to 278)
105
(91 to 122)
90
(65 to 118)
–5·2% 
(–6·6 to –3·6)
–2·9% 
(–6·5 to 0·4)
–4·2% 
(–5·6 to –2·9)
Kyrgyzstan 62·5 
(54·3 to 71·4)
58·3 
(50·6 to 66·8)
46·8 
(35·9 to 59·2)
84
(73 to 95)
66
(58 to 76)
69
(53 to 88)
–0·5% 
(–2·1 to 1·0)
–2·3% 
(–5·2 to 0·5)
–1·3% 
(–2·5 to –0·1)
Mongolia 180·2 
(137·4 to 233·0)
96·3 
(74·6 to 122·7)
51·3 
(34·2 to 72·3)
108
(82 to 139)
50
(39 to 63)
33
(22 to 46)
–4·8% 
(–7·5 to –2·1)
–6·4% 
(–10·7 to –2·1)
–5·5% 
(–7·5 to –3·6)
Tajikistan 74·6 
(65·3 to 86·4)
49·4 
(42·2 to 57·8)
30·4 
(22·2 to 39·3)
154
(135 to 178)
98
(84 to 115)
82
(60 to 106)
–3·2% 
(–4·9 to –1·6)
–4·9% 
(–8·2 to –1·9)
–3·9% 
(–5·4 to –2·7)
Turkmeni stan 72·9 
(63·2 to 83·1)
61·2
(41·1 to 83·7)
38·2 
(22·9 to 55·5)
91
(79 to 103)
64
(43 to 88)
42
(25 to 61)
–1·4% 
(–4·6 to 1·3)
–4·8% 
(–9·7 to –0·1)
–2·9% 
(–5·0 to –1·1)
Uzbekistan 50·7 
(45·4 to 56·8)
42·4 
(36·6 to 48·9)
30·5 
(21·0 to 42·6)
353
(315 to 395)
249
(215 to 287)
187
(129 to 262)
–1·4% 
(–2·8 to –0·1)
–3·4% 
(–6·8 to 0·4)
–2·3% 
(–3·9 to –0·7)
East Asia 139·5 
(113·1 to 167·1)
63·9 
(58·1 to 69·7)
18·2 
(15·0 to 21·3)
31 690
(25 695 to 37 974)
11 084
(10 075 to 12 080)
3534
(2925 to 4135)
–6·0% 
(–7·6 to –4·3)
–12·6% 
(–14·5 to –10·7)
–8·9% 
(–10·1 to –7·6)
China 141·7 
(114·4 to 170·8)
64·1
(58·2 to 70·1)
17·2 
(14·0 to 20·3)
31 042
(25 074 to 37 428)
10 652
(9667 to 11 643)
3233
(2633 to 3815)
–6·1% 
(–7·8 to –4·3)
–13·2% 
(–15·2 to –11·1)
–9·2% 
(–10·4 to –7·8)
North Korea 136·3 
(70·2 to 226·7)
100·5 
(67·8 to 144·1)
77·4 
(48·3 to 111·9)
546
(281 to 908)
386
(260 to 554)
275
(172 to 398)
–2·2% 
(–6·5 to 2·5)
–2·6% 
(–7·4 to 2·5)
–2·4% 
(–5·6 to 1·1)
Taiwan 
(Province 
of China)
24·9 
(17·3 to 33·8)
13·5
(10·1 to 17·8)
7·9
(6·1 to 10·2)
102
 (71 to 138)
46
(34 to 60)
26
(20 to 33)
–4·7% 
(–7·7 to –1·8)
–5·3% 
(–9·0 to –1·7)
–5·0% 
(–6·6 to –3·2)
South Asia 480·4 
(407·4 to 558·3)
399·7 
(345·8 to 467·6)
310·6 
(252·4 to 383·4)
174 416 
(147 914 to 202 689)
142 624 
(123 413 to 166 876)
107 827 
(87 629 to 133 087)
–1·4% 
(–3·0 to 0·3)
–2·6% 
(–5·1 to 0·0)
–1·9% 
(–3·0 to –0·8)
Afghanistan 501·0 
(324·4 to 739·0)
716·3 
(441·3 to 1123·4)
885·0 
(508·7 to 1445·1)
3261
(2112 to 4811)
7726
(4760 to 12 117)
8794
(5055 to 14 360)
2·7% 
(–0·6 to 5·8)
2·1% 
(–1·8 to 5·4)
2·4% 
(0·1 to 4·7)
Bangladesh 551·9 
(436·4 to 659·5)
333·1 
(250·9 to 427·6)
242·7 
(171·2 to 326·9)
20 669
(16 345 to 24 701)
11 327
(8532 to 14 541)
7737
(5459 to 10 422)
–3·9% 
(–6·4 to –1·3)
–3·2% 
(–7·0 to 0·8)
–3·6% 
(–5·1 to –1·9)
Bhutan 551·7 
(275·0 to 846·5)
411·2 
(204·9 to 651·7)
277·4 
(136·7 to 469·2)
106
(53 to 162)
59
(30 to 94)
40
(20 to 68)
–2·3% 
(–6·4 to 1·5)
–4·0% 
(–8·1 to 0·9)
–3·0% 
(–5·8 to 0·2)
India 480·8 
(384·9 to 583·6)
382·0 
(315·3 to 472·8)
281·8 
(207·0 to 371·2)
128 695
(103 026 to 156 193)
100 014
(82 553 to 123 801)
71 792
(52 723 to 94 564)
–1·8% 
(–4·0 to 0·6)
–3·1% 
(–6·6 to 0·3)
–2·3% 
(–3·9 to –0·8)
Nepal 417·4 
(295·9 to 540·8)
365·0 
(262·6 to 464·3)
272·3 
(190·9 to 363·5)
3012
(2136 to 3903)
2623
(1886 to 3336)
1588
(1113 to 2119)
–1·0% 
(–3·6 to 1·5)
–3·0% 
(–6·0 to –0·1)
–1·9% 
(–3·7 to 0·1)
(Table 1 continues on next page)
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Maternal mortality ratio (per 100 000 livebirths) Number of maternal deaths Annualised rate of change in maternal 
mortality ratio (%)
1990 2003 2013 1990 2003 2013 1990–2003 2003–13 1990–2013
(Continued from previous page)
Pakistan 423·9 
(317·2 to 521·6)
486·5 
(360·7 to 595·6)
400·6 
(233·0 to 560·8)
18 673
(13 973 to 22 976)
20 875
(15 477 to 25 557)
17 876
(10 397 to 25 026)
1·1% 
(–1·6 to 3·7)
–2·1% 
(–7·7 to 2·4)
–0·3% 
(–2·9 to 1·8)
Southeast Asia 295·0 
(247·5 to 353·4)
217·4 
(180·8 to 266·3)
154·9 
(124·2 to 192·9)
35 339
(29 644 to 42 340)
25 637
(21 327 to 31 404)
18 028
(14 456 to 22 444)
–2·3% 
(–3·6 to –1·1)
–3·4% 
(–5·4 to –1·6)
–2·8% 
(–4·0 to –1·8)
Cambodia 355·9 
(290·5 to 415·7)
399·0 
(277·9 to 486·8)
220·9 
(155·6 to 286·5)
1290
(1053 to 1507)
1355
(944 to 1654)
862
(607 to 1118)
0·8% 
(–1·8 to 2·8)
–5·9% 
(–9·3 to –2·9)
–2·1% 
(–3·6 to –0·6)
Indonesia 368·3 
(311·6 to 432·9)
262·0 
(224·3 to 308·2)
199·3 
(149·4 to 257·4)
16 519
(13 975 to 19 416)
12 734
(10 902 to 14 982)
9352
7010 to 12 079)
–2·6% 
(–4·2 to –1·0)
–2·8% 
(–6·1 to 0·0)
–2·7% 
(–4·3 to –1·4)
Laos 514·4 
(276·7 to 767·0)
490·7 
(251·3 to 779·6)
303·8 
(154·7 to 521·5)
942
(506 to 1404)
814
(417 to 1293)
543
(277 to 932)
–0·4% 
(–4·1 to 2·7)
–4·8% 
(–8·3 to –1·1)
–2·3% 
(–4·7 to 0·3)
Malaysia 101·6 
(84·3 to 120·3)
78·4
(70·7 to 87·5)
55·7 
(43·1 to 70·6)
522
(433 to 617)
364
(328 to 406)
291
(226 to 369)
–2·0% 
(–3·5 to –0·4)
–3·5% 
(–6·0 to –0·8)
–2·6% 
(–3·9 to –1·3)
Maldives 292·3 
(240·8 to 355·1)
95·4 
(78·7 to 111·6)
51·8 
(38·6 to 67·0)
23
(19 to 28)
6
(5 to 7)
4
(3 to 5)
–8·6% 
(–10·3 to –6·7)
–6·2% 
(–9·5 to –3·0)
–7·5% 
(–9·1 to –6·0)
Myanmar 897·3 
(513·3 to 1460·4)
645·6 
(332·2 to 1145·2)
390·9 
(196·3 to 731·7)
9465
(5414 to 15 405)
6108
(3144 to 10 835)
3531
(1773 to 6609)
–2·6% 
(–6·1 to 0·6)
–5·1% 
(–8·8 to –1·0)
–3·7% 
(–6·0 to –0·9)
Philippines 116·3 
(103·4 to 130·2)
81·5
(72·0 to 91·5)
80·9 
(54·9 to 115·0)
2374
(2112 to 2658)
1876
(1657 to 2105)
1959
(1328 to 2784)
–2·7% 
(–3·9 to –1·5)
–0·2% 
(–4·3 to 3·5)
–1·6% 
(–3·3 to –0·1)
Sri Lanka 73·6 
(61·8 to 89·0)
47·9 
(38·9 to 56·7)
30·9 
(20·7 to 43·4)
257
(216 to 311)
178
(144 to 211)
116
(77 to 162)
–3·3% 
(–5·3 to –1·7)
–4·5% 
(–8·6 to –0·6)
–3·8% 
(–5·9 to –2·1)
Thailand 42·6 
(36·1 to 50·3)
89·6 
(75·9 to 104·4)
69·5 
(47·3 to 98·7)
456
(386 to 538)
766
(648 to 892)
481
(328 to 684)
5·7% 
(3·8 to 7·5)
–2·7% 
(–6·6 to 1·4)
2·1% 
(0·3 to 3·9)
Timor-Leste 632·8 
(490·8 to 781·3)
430·2 
(361·6 to 498·6)
223·4 
(175·5 to 275·9)
215
(167 to 266)
156
(131 to 181)
89
(70 to 110)
–2·9% 
(–4·9 to –0·9)
–6·6% 
(–9·0 to –4·2)
–4·5% 
(–6·0 to –3·1)
Vietnam 174·5 
(124·5 to 239·1)
88·5 
(59·4 to 122·0)
56·6 
(34·1 to 89·5)
3275
(2337 to 4487)
1281
(860 to 1766)
800
(482 to 1265)
–5·2% 
(–8·3 to –2·2)
–4·6% 
(–9·1 to 0·0)
–5·0% 
(–7·5 to –2·3)
Australasia 8·1
(7·1 to 9·2)
5·9
(5·2 to 6·7)
5·5
(4·5 to 6·6)
26
(22 to 29)
19
(17 to 22)
21
(17 to 25)
–2·4% 
(–3·7 to –1·0)
–0·7% 
(–2·7 to 1·3)
–1·7% 
(–2·6 to –0·6)
Australia 7·0
(6·0 to 8·2)
5·1
(4·4 to 6·0)
4·8
(3·7 to 5·9)
18
(16 to 21)
14
(12 to 16)
15
(12 to 18)
–2·5% 
(–4·1 to –0·8)
–0·7% 
(–3·2 to 2·0)
–1·7% 
(–3·0 to –0·5)
New Zealand 12·6 
(10·3 to 15·2)
9·4
(7·9 to 11·3)
9·3
(7·2 to 12·1)
7
(6 to 9)
6
(5 to 7)
6
(4 to 7)
–2·2% 
(–4·2 to –0·3)
–0·1% 
(–3·0 to 2·7)
–1·3% 
(–2·8 to 0·1)
Caribbean 208·3 
(165·9 to 248·8)
213·1 
(161·4 to 272·2)
150·0 
(110·1 to 206·7)
1664
(1325 to 1987)
1602
(1214 to 2047)
1075
(788 to 1480)
0·1% 
(–1·5 to 1·7)
–3·5% 
(–6·1 to –1·0)
–1·5% 
(–2·6 to –0·1)
Antigua and 
Barbuda
54·4 
(40·1 to 69·4)
50·8 
(40·1 to 64·2)
42·0 
(27·9 to 62·3)
1
(1 to 1)
1
(1 to 1)
1
(0 to 1)
–0·5% 
(–3·2 to 2·1)
–2·0% 
(–6·4 to 2·7)
–1·2% 
(–3·1 to 1·1)
Barbados 69·4 
(54·8 to 87·4)
62·3
(50·4 to 75·0)
49·9 
(34·3 to 70·7)
3
(2 to 4)
2
(2 to 3)
2
(1 to 3)
–0·8% 
(–3·0 to 1·4)
–2·3% 
(–6·2 to 1·7)
–1·5% 
(–3·2 to 0·4)
Belize 32·1 
(26·2 to 39·5)
42·5 
(34·9 to 51·6)
55·5 
(37·6 to 78·9)
2
(2 to 3)
3
(2 to 4)
4
(3 to 6)
2·2% 
(0·1 to 4·2)
2·5% 
(–1·4 to 6·3)
2·3% 
(0·3 to 4·1)
Cuba 71·1 
(59·6 to 87·0)
60·6 
(52·4 to 70·2)
39·8 
(31·5 to 49·5)
123
(103 to 150)
82
(71 to 95)
44
(35 to 54)
–1·2% 
(–3·0 to 0·4)
–4·3% 
(–6·9 to –1·6)
–2·5% 
(–3·8 to –1·2)
Dominica 50·2 
(39·2 to 65·9)
41·4
(32·4 to 52·2)
36·1 
(23·2 to 52·7)
1
(1 to 1)
1
(0 to 1)
0
(0 to 1)
–1·5% 
(–4·2 to 1·0)
–1·5% 
(–5·9 to 2·6)
–1·5% 
(–3·6 to 0·6)
Dominican 
Republic
73·8 
(62·8 to 85·8)
60·5 
(52·2 to 69·8)
40·8 
(28·9 to 55·8)
164
(139 to 191)
138
(119 to 159)
90
(64 to 124)
–1·5% 
(–2·9 to 0·0)
–4·1% 
(–7·6 to –0·8)
–2·6% 
(–4·2 to –1·1)
Grenada 47·7 
(37·6 to 62·4)
62·5 
(50·6 to 76·6)
56·7 
(41·0 to 76·9)
1
(1 to 2)
1
(1 to 1)
1
(1 to 2)
2·1% 
(–0·2 to 4·5)
–1·1% 
(–4·7 to 2·4)
0·7% 
(–1·0 to 2·4)
Guyana 118·8 
(98·5 to 142·0)
138·9 
(111·4 to 169·2)
118·1 
(75·8 to 179·4)
21
(17 to 25)
25
(20 to 30)
20
(13 to 30)
1·2% 
(–1·0 to 3·3)
–1·8% 
(–6·1 to 2·4)
–0·1% 
(–2·1 to 2·0)
Haiti 492·4 
(363·4 to 619·7)
495·7 
(351·1 to 662·0)
333·0 
(219·1 to 480·1)
1290
(952 to 1624)
1289
(913 to 1722)
868
(571 to 1251)
0·0% 
(–2·0 to 2·1)
–4·0% 
(–7·2 to –1·0)
–1·7% 
(–3·2 to –0·1)
Jamaica 44·0 
(32·4 to 58·1)
59·4 
(48·6 to 71·2)
44·7 
(29·7 to 66·0)
27
(20 to 36)
33
(27 to 40)
23
(15 to 34)
2·3% 
(–0·2 to 5·0)
–3·0% 
(–7·0 to 1·2)
0·0% 
(–2·0 to 2·1)
Saint Lucia 52·0 
(40·8 to 68·7)
44·4 
(35·5 to 54·3)
41·0 
(28·0 to 58·8)
2
(2 to 3)
1
(1 to 2)
1
(1 to 2)
–1·2% 
(–3·9 to 1·3)
–0·9% 
(–4·6 to 3·2)
–1·1% 
(–3·1 to 0·7)
(Table 1 continues on next page)
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Saint Vincent 
and the 
Grenadines
45·2 
(33·3 to 60·8)
65·7
(54·0 to 81·7)
60·1 
(43·7 to 80·8)
1
(1 to 2)
1
(1 to 2)
1
(1 to 1)
2·9% 
(0·2 to 5·7)
–1·0% 
(–4·6 to 2·3)
1·2% 
(–0·7 to 3·2)
Suriname 76·8 
(62·3 to 93·2)
88·2 
(71·3 to 106·5)
65·2 
(44·2 to 91·3)
7
(6 to 9)
9
(7 to 11)
6
(4 to 9)
1·1% 
(–1·1 to 3·2)
–3·1% 
(–7·6 to 1·0)
–0·8% 
(–2·6 to 1·1)
The Bahamas 63·1 
(48·0 to 84·0)
71·8
(57·5 to 90·2)
60·3 
(38·8 to 91·2)
4
(3 to 5)
4
(3 to 5)
4
(2 to 5)
1·0% 
(–1·7 to 3·5)
–1·9% 
(–6·5 to 2·4)
–0·3% 
(–2·4 to 2·1)
Trinidad and 
Tobago
72·3 
(61·5 to 84·3)
64·4 
(54·1 to 75·8)
49·7 
(36·4 to 65·6)
17
(14 to 20)
13
(11 to 15)
10
(7 to 13)
–0·9% 
(–2·6 to 0·9)
–2·7% 
(–5·8 to 0·5)
–1·7% 
(–3·1 to –0·2)
Central Europe 48·9 
(45·4 to 53·0)
15·4
(14·1 to 16·5)
8·8
 (7·5 to 10·1)
790
(734 to 856)
189
(173 to 203)
112
(95 to 128)
–8·9% 
(–9·7 to –8·2)
–5·6% 
(–7·1 to –4·1)
–7·4% 
(–8·2 to –6·8)
Albania 35·3 
(29·5 to 41·6)
13·2
(10·8 to 16·1)
7·3
(4·9 to 10·2)
30
(25 to 35)
6
(5 to 8)
3
(2 to 4)
–7·6% 
(–9·7 to –5·5)
–6·1% 
(–10·4 to 
–2·2)
–6·9% 
(–8·7 to –5·2)
Bosnia and 
Herzegovina
38·8 
(31·2 to 47·0)
20·4 
(14·8 to 27·6)
11·0
(7·7 to 15·3)
23
(19 to 28)
7
(5 to 9)
4
(3 to 5)
–5·0% 
(–7·8 to –2·3)
–6·3% 
(–10·1 to 
–2·5)
–5·5% 
(–7·2 to –3·8)
Bulgaria 44·3 
(38·8 to 50·7)
29·2
(24·9 to 33·7)
14·8 
(12·0 to 18·2)
43
(37 to 49)
22
(18 to 25)
11
(9 to 13)
–3·2% 
(–4·8 to –1·7)
–6·8% 
(–9·0 to –4·5)
–4·8% 
(–5·7 to –3·8)
Croatia 16·9 
(14·1 to 20·1)
12·7
(10·5 to 14·9)
9·9
(7·9 to 12·3)
9
(7 to 11)
5
(4 to 6)
4
(3 to 5)
–2·2% 
(–4·0 to –0·5)
–2·5% 
(–4·9 to 0·0)
–2·3% 
(–3·6 to –1·1)
Czech 
Republic
18·1 
(15·2 to 21·4)
7·0
(5·8 to 8·4)
5·3
(4·1 to 6·7)
22
(18 to 26)
7
(6 to 9)
6
(5 to 8)
–7·3% 
(–9·2 to –5·4)
–2·8% 
(–5·6 to –0·2)
–5·3% 
(–6·6 to –4·1)
Hungary 19·0 
(16·0 to 22·5)
9·2
(7·6 to 11·0)
8·5
(6·3 to 10·7)
24
(20 to 28)
9
(7 to 11)
9
(6 to 11)
–5·6% 
(–7·5 to –3·7)
–0·8% 
(–3·7 to 1·9)
–3·5% 
(–4·9 to –2·3)
Macedonia 25·1 
(20·1 to 31·3)
17·7
(14·7 to 21·0)
10·5
(8·2 to 13·3)
9
(7 to 11)
4
(4 to 5)
2
(2 to 3)
–2·7% 
(–4·8 to –0·6)
–5·2% 
(–7·6 to –2·4)
–3·8% 
(–5·3 to –2·3)
Montenegro 15·9 
(10·4 to 23·0)
18·6 
(14·0 to 24·0)
12·3
(8·6 to 17·3)
1
(1 to 2)
1
(1 to 2)
1
(1 to 1)
1·3% 
(–2·2 to 4·7)
–4·2% 
(–7·8 to –0·2)
–1·1% 
(–3·3 to 1·1)
Poland 34·0 
(30·3 to 38·2)
8·6
(7·4 to 9·9)
4·8
(3·8 to 6·1)
179
(159 to 201)
33
(28 to 37)
20
(16 to 26)
–10·6% 
(–12·0 to –9·3)
–5·8% 
(–8·5 to –3·4)
–8·5% 
(–9·6 to –7·4)
Romania 152·1 
(137·4 to 169·5)
31·6
(27·9 to 35·5)
15·9 
(12·2 to 19·9)
414
(374 to 462)
73
(65 to 82)
37
(28 to 46)
–12·1% 
(–13·3 to –10·9)
–6·9% 
(–9·6 to –4·3)
–9·8% 
(–11·1 to –8·7)
Serbia 15·8
(11·0 to 22·9)
12·1
(10·1 to 14·2)
10·6
(8·5 to 13·0)
22
(15 to 32)
13
(11 to 16)
10
(8 to 12)
–2·0%
(–5·1 to 1·0)
–1·3%
(–3·8 to 1·2)
–1·7%
(–3·6 to 0·1)
Slovakia 15·9 
(12·7 to 19·5)
9·5
(8·0 to 11·1)
6·2
(4·8 to 7·9)
12
(10 to 15)
5
(4 to 6)
4
(3 to 5)
–4·0% 
(–6·1 to –2·0)
–4·3% 
(–7·1 to –1·6)
–4·1% 
(–5·5 to –2·8)
Slovenia 12·9 
(10·6 to 15·7)
11·0
(8·8 to 13·3)
7·4
(5·5 to 9·8)
3
(2 to 3)
2
(2 to 3)
2
(1 to 2)
–1·2% 
(–3·2 to 0·8)
–4·1% 
(–7·3 to –0·8)
–2·5% 
(–3·9 to –1·0)
Eastern Europe 60·1 
(54·3 to 65·7)
36·3 
(32·8 to 40·4)
17·6 
(14·4 to 20·6)
1566
(1415 to 1714)
812
(733 to 904)
433
(354 to 507)
–3·9% 
(–4·9 to –2·8)
–7·3% 
(–9·4 to –5·4)
–5·3% 
(–6·1 to –4·6)
Belarus 40·5 
(35·1 to 46·3)
25·0 
(20·8 to 30·0)
10·6
(7·7 to 13·9)
53
(46 to 60)
25
(20 to 30)
11
(8 to 15)
–3·7% 
(–5·4 to –1·9)
–8·7% 
(–11·9 to –5·5)
–5·9% 
(–7·2 to –4·5)
Estonia 45·1 
(37·4 to 54·1)
17·7
(14·7 to 21·5)
7·1
(4·9 to 9·5)
8
(7 to 10)
3
(2 to 3)
1
(1 to 1)
–7·2% 
(–9·2 to –5·3)
–9·2% 
(–12·7 to –5·8)
–8·1% 
(–9·9 to –6·6)
Latvia 49·7 
(42·2 to 58·1)
20·8
(17·1 to 24·5)
8·5
(6·2 to 11·1)
16
(13 to 18)
5
(4 to 6)
2
(1 to 3)
–6·7% 
(–8·5 to –5·0)
–9·0% 
(–12·3 to –6·3)
–7·7% 
(–9·2 to –6·4)
Lithuania 29·6 
(24·9 to 34·9)
13·7
(11·5 to 16·3)
6·1
(4·6 to 7·8)
15
(13 to 18)
5
(4 to 5)
2
(2 to 3)
–5·9% 
(–7·7 to –4·0)
–8·2% 
(–11·1 to –5·2)
–6·9% 
(–8·3 to –5·6)
Moldova 68·9 
(59·7 to 79·6)
34·7
(28·5 to 41·3)
21·8 
(16·0 to 28·2)
50
(43 to 57)
16
(13 to 19)
9
(7 to 12)
–5·3% 
(–7·2 to –3·4)
–4·7% 
(–7·7 to –1·8)
–5·0% 
(–6·6 to –3·7)
Russia 64·9 
(57·7 to 72·6)
36·9 
(32·5 to 42·0)
16·8 
(13·5 to 20·2)
1099
(976 to 1229)
575
(507 to 655)
291
(234 to 351)
–4·4% 
(–5·7 to –2·9)
–7·9% 
(–10·5 to –5·6)
–5·9% 
(–6·8 to –5·0)
Ukraine 53·3 
(46·3 to 60·8)
39·6 
(34·5 to 45·4)
23·1 
(17·5 to 29·2)
326
 (283 to 372)
184
(161 to 211)
116
(88 to 147)
–2·3% 
(–3·7 to –0·8)
–5·4% 
(–8·4 to –2·7)
–3·7% 
(–4·9 to –2·5)
Western Europe 12·7 
(11·7 to 13·8)
8·1
(7·3 to 8·6)
6·3
(5·3 to 7·1)
565
 (522 to 615)
365
 (330 to 390)
288
(243 to 326)
–3·5% 
(–4·2 to –2·9)
–2·5% 
(–3·8 to –1·4)
–3·1% 
(–3·8 to –2·5)
(Table 1 continues on next page)
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Andorra 5·5
(3·1 to 9·0)
3·1
(1·9 to 4·9)
3·0
(1·6 to 4·8)
0
(0 to 0)
0
(0 to 0)
0
(0 to 0)
–4·4% 
(–9·2 to 0·1)
–0·6% 
(–6·3 to 5·6)
–2·7% 
(–5·9 to 0·2)
Austria 10·3
(8·5 to 12·2)
5·0
(4·0 to 6·0)
3·2
(2·3 to 4·0)
9
(8 to 11)
4
(3 to 5)
3
(2 to 3)
–5·6% 
(–7·5 to –3·6)
–4·5% 
(–7·4 to –1·8)
–5·1% 
(–6·5 to –3·8)
Belgium 11·3
(9·4 to 13·3)
8·4
(6·9 to 10·1)
6·7
(5·0 to 8·6)
14
(12 to 16)
10
(8 to 12)
9
(7 to 11)
–2·2% 
(–4·0 to –0·5)
–2·3% 
(–5·2 to 0·5)
–2·3% 
(–3·6 to –1·0)
Cyprus 13·3
(9·6 to 17·7)
8·7
(6·7 to 11·0)
6·1
(4·4 to 8·1)
2
(1 to 3)
1
(1 to 1)
1
(1 to 1)
–3·2% 
(–6·0 to –0·4)
–3·6% 
(–7·4 to 0·1)
–3·4% 
(–5·2 to –1·6)
Denmark 7·4
(6·2 to 9·1)
5·8
(4·7 to 7·1)
4·8
(3·4 to 6·2)
5
(4 to 6)
4
(3 to 5)
3
(2 to 4)
–1·9% 
(–4·4 to 0·1)
–2·1% 
(–5·0 to 0·7)
–2·0% 
(–3·7 to –0·5)
Finland 7·2
(5·9 to 8·8)
6·4
(5·3 to 7·6)
3·9
(3·0 to 5·0)
5
(4 to 6)
4
(3 to 4)
2
(2 to 3)
–0·9% 
(–2·8 to 1·0)
–5·0% 
(–7·6 to –2·3)
–2·7% 
(–4·1 to –1·4)
France 15·6 
(13·5 to 17·7)
11·0
(9·3 to 12·6)
8·8
(6·9 to 11·0)
116
(100 to 132)
87
(74 to 100)
70
(55 to 88)
–2·7% 
(–4·1 to –1·2)
–2·2% 
(–4·5 to 0·2)
–2·5% 
(–3·7 to –1·3)
Germany 18·0 
(15·9 to 20·4)
8·3
(7·1 to 9·6)
6·5
(5·0 to 7·9)
146
 (129 to 165)
62
(52 to 71)
46
(36 to 56)
–5·9% 
(–7·4 to –4·7)
–2·5% 
(–4·6 to –0·5)
–4·4% 
(–5·6 to –3·4)
Greece 9·5
(8·0 to 11·1)
7·9
(6·6 to 9·3)
9·1
(7·2 to 11·3)
10
(8 to 11)
9
(7 to 11)
10
(8 to 12)
–1·4% 
(–3·2 to 0·2)
1·4% 
(–1·0 to 4·0)
–0·2% 
(–1·3 to 1·0)
Iceland 7·1
(5·5 to 9·0)
4·2
(3·0 to 5·6)
2·4
(1·6 to 3·6)
0
(0 to 0)
0
(0 to 0)
0
(0 to 0)
–4·1% 
(–7·1 to –1·1)
–5·4% 
(–9·9 to –1·0)
–4·7% 
(–6·9 to –2·6)
Ireland 6·3
(5·2 to 7·6)
3·9
(3·1 to 4·7)
3·3
(2·3 to 4·4)
3
(3 to 4)
2
(2 to 3)
2
(2 to 3)
–3·7% 
(–5·6 to –1·9)
–1·7% 
(–5·0 to 1·7)
–2·8% 
(–4·4 to –1·3)
Israel 10·4
(8·8 to 12·5)
7·1
(5·9 to 8·5)
4·4
(3·2 to 5·5)
10
(9 to 12)
10
(8 to 12)
7
(5 to 9)
–2·9% 
(–4·8 to –1·1)
–4·9% 
(–8·2 to –2·2)
–3·8% 
(–5·4 to –2·4)
Italy 9·9
(8·6 to 11·4)
5·7
(4·7 to 6·7)
4·3
(3·2 to 5·5)
54
(47 to 63)
32
(27 to 38)
24
(18 to 32)
–4·3% 
(–5·8 to –2·7)
–2·8% 
(–5·7 to –0·2)
–3·7% 
(–5·0 to –2·4)
Luxembourg 5·0
(4·1 to 6·1)
7·0
(5·4 to 8·6)
6·1
(4·5 to 8·0)
0
(0 to 0)
0
(0 to 0)
0
(0 to 1)
2·6% 
(0·3 to 4·6)
–1·5% 
(–4·7 to 2·0)
0·8% 
(–0·8 to 2·4)
Malta 6·9
(5·5 to 8·4)
5·4
(4·2 to 6·9)
2·9
(2·0 to 3·9)
0
(0 to 1)
0
(0 to 0)
0
(0 to 0)
–1·8% 
(–4·3 to 0·5)
–6·5% 
(–10·4 to –2·8)
–3·8% 
(–5·6 to –2·1)
Netherlands 11·7
(9·8 to 13·9)
10·8
(8·9 to 12·7)
6·7
(5·1 to 8·3)
23
(19 to 27)
22
(18 to 25)
12
(9 to 15)
–0·6% 
(–2·3 to 1·0)
–4·8% 
(–7·4 to –2·1)
–2·5% 
(–3·7 to –1·3)
Norway 5·9
(4·9 to 7·1)
6·3
(5·1 to 7·7)
4·5
(3·5 to 5·6)
4
(3 to 4)
4
(3 to 5)
3
(2 to 4)
0·5% 
(–1·4 to 2·5)
–3·4% 
(–6·0 to –0·7)
–1·2% 
(–2·4 to 0·1)
Portugal 20·6 
(17·7 to 24·1)
13·6
(11·5 to 16·0)
9·8
(7·7 to 12·2)
23
(20 to 27)
15
(13 to 17)
9
(7 to 11)
–3·2% 
(–4·9 to –1·5)
–3·3% 
(–6·0 to –0·8)
–3·3% 
(–4·4 to –2·1)
Spain 12·3 
(10·7 to 14·3)
7·0
(6·0 to 8·2)
6·2
(4·8 to 7·6)
47
(41 to 54)
32
(28 to 37)
31
(24 to 38)
–4·3% 
(–5·8 to –2·8)
–1·4% 
(–3·8 to 1·2)
–3·0% 
(–4·2 to –1·9)
Sweden 7·0
(5·7 to 8·6)
4·9
(3·9 to 5·9)
3·7
(2·7 to 4·8)
8
(7 to 10)
5
(4 to 6)
4
(3 to 6)
–2·7% 
(–4·9 to –0·7)
–2·8% 
(–6·1 to 0·1)
–2·7% 
(–4·5 to –1·3)
Switzerland 6·7
(5·5 to 8·3)
5·8
(4·6 to 7·2)
3·9
(2·9 to 5·1)
5
(4 to 7)
4
(3 to 5)
3
(2 to 4)
–1·1% 
(–3·4 to 1·1)
–4·0% 
(–7·0 to –1·0)
–2·3% 
(–4·1 to –0·9)
UK 10·4
(9·4 to 11·1)
7·7
(7·0 to 8·3)
6·1
(5·2 to 6·9)
80
(73 to 86)
57
(52 to 62)
47
(40 to 54)
–2·3% 
(–2·9 to –1·7)
–2·4% 
(–3·8 to –1·0)
–2·3% 
(–3·0 to –1·7)
Andean 
Latin America
187·9 
(169·5 to 208·7)
112·5 
(99·7 to 125·1)
96·0 
(75·3 to 117·2)
2249
(2028 to 2497)
1366
(1211 to 1520)
1164
(912 to 1421)
–4·0% 
(–5·2 to –2·8)
–1·6% 
(–4·0 to 0·6)
–2·9% 
(–4·1 to –2·0)
Bolivia 382·4 
(312·1 to 458·1)
229·9 
(178·7 to 281·9)
179·6 
(110·4 to 257·2)
977
(798 to 1171)
616
(479 to 755)
499
(307 to 715)
–3·9% 
(–6·3 to –1·7)
–2·6% 
(–6·9 to 1·3)
–3·4% 
(–5·6 to –1·5)
Ecuador 142·7 
(128·4 to 159·9)
86·0 
(72·8 to 100·3)
84·6 
(57·7 to 122·0)
430
(386 to 481)
282
(239 to 329)
282
(192 to 406)
–3·9% 
(–5·4 to –2·4)
–0·3% 
(–4·6 to 3·7)
–2·3% 
(–4·1 to –0·7)
Peru 131·5 
(114·1 to 152·6)
75·7 
(64·6 to 88·4)
63·7 
(45·6 to 85·4)
842
(731 to 977)
468
(400 to 547)
383
(274 to 513)
–4·3% 
(–5·9 to –2·6)
–1·8% 
(–5·2 to 1·6)
–3·2% 
(–4·8 to –1·7)
Central 
Latin America
78·8 
(74·9 to 82·3)
67·9
(63·7 to 72·6)
59·9 
(53·8 to 66·7)
3884
(3690 to 4056)
3446
(3231 to 3683)
2950
(2649 to 3283)
–1·1% 
(–1·6 to –0·7)
–1·3% 
(–2·2 to –0·2)
–1·2% 
(–1·6 to –0·7)
Colombia 68·2 
(60·7 to 76·7)
77·1
(67·2 to 87·7)
62·9 
(44·1 to 85·2)
633
(563 to 712)
725
(632 to 824)
577
(405 to 782)
0·9% 
(–0·3 to 2·2)
–2·2% 
(–5·6 to 1·2)
–0·4% 
(–1·9 to 1·0)
(Table 1 continues on next page)
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Costa Rica 31·1 
(26·9 to 36·0)
36·3
(31·7 to 41·5)
24·9 
(20·1 to 30·3)
25
(22 to 29)
28
(24 to 31)
19
(15 to 23)
1·2% 
(–0·3 to 2·7)
–3·8% 
(–6·0 to –1·5)
–1·0% 
(–2·0 to 0·1)
El Salvador 105·5 
(90·2 to 120·4)
57·5 
(49·2 to 66·5)
65·8 
(44·3 to 91·6)
181
(155 to 206)
77
(66 to 89)
86
(58 to 119)
–4·7% 
(–6·3 to –3·1)
1·2% 
(–2·6 to 4·9)
–2·1% 
(–3·8 to –0·4)
Guatemala 112·8 
(101·0 to 126·2)
91·8 
(81·2 to 104·2)
86·7 
(65·8 to 110·8)
409
 (367 to 458)
400
(353 to 454)
423
(321 to 541)
–1·6% 
(–2·8 to –0·4)
–0·6% 
(–3·5 to 2·0)
–1·2% 
(–2·4 to 0·0)
Honduras 153·1 
(90·5 to 190·4)
119·5 
(48·5 to 191·2)
72·0 
(35·5 to 123·0)
295
(175 to 367)
238
(97 to 381)
153
(75 to 260)
–2·1% 
(–6·4 to 1·5)
–5·1% 
(–10·5 to 0·2)
–3·4% 
(–5·8 to –1·1)
Mexico 73·8 
(70·4 to 77·1)
57·9
(55·0 to 60·5)
54·0 
(50·3 to 58·2)
1774
(1691 to 1851)
1429
(1357 to 1493)
1224
(1139 to 1320)
–1·9% 
(–2·3 to –1·5)
–0·7% 
(–1·5 to 0·1)
–1·4% 
(–1·7 to –1·0)
Nicaragua 94·5 
(81·2 to 109·4)
87·8 
(76·7 to 101·0)
63·5 
(49·0 to 80·0)
148
(127 to 171)
126
(110 to 145)
90
(69 to 113)
–0·6% 
(–2·1 to 1·0)
–3·3% 
(–6·2 to –0·7)
–1·8% 
(–3·0 to –0·5)
Panama 62·3 
(53·0 to 72·7)
66·2
(57·2 to 76·3)
55·2 
(40·6 to 73·2)
42
(35 to 49)
50
(44 to 58)
42
(31 to 56)
0·5% 
(–1·1 to 2·2)
–1·9% 
(–5·1 to 1·3)
–0·6% 
(–1·9 to 0·8)
Venezuela 66·6 
(59·6 to 73·5)
62·0 
(56·3 to 68·7)
54·7 
(42·8 to 68·6)
377
(337 to 415)
373
(339 to 413)
336
(263 to 421)
–0·5% 
(–1·6 to 0·5)
–1·3% 
(–3·8 to 1·2)
–0·9% 
(–2·0 to 0·2)
Southern 
Latin America
55·5
(51·1 to 60·2)
51·2
(46·3 to 55·8)
44·2
(37·3 to 51·3)
603
(555 to 653)
513
(465 to 560)
445
(376 to 518)
–0·6% 
(–1·6 to 0·2)
–1·5% 
(–3·3 to 0·3)
–1·0% 
(–1·8 to –0·2)
Argentina 60·2 
(54·9 to 66·0)
63·3
(57·0 to 69·7)
54·7 
(45·3 to 64·6)
434
(396 to 476)
440
(396 to 484)
387
(320 to 456)
0·4% 
(–0·7 to 1·4)
–1·5% 
(–3·5 to 0·5)
–0·4% 
(–1·3 to 0·4)
Chile 47·8 
(42·3 to 54·3)
22·0
(19·3 to 25·0)
18·7 
(14·7 to 23·2)
146
(130 to 166)
56
(49 to 64)
47
(37 to 58)
–6·0% 
(–7·4 to –4·6)
–1·7% 
(–4·2 to 0·9)
–4·1% 
(–5·2 to –3·0)
Uruguay 38·7 
(32·8 to 45·3)
32·5
(27·4 to 38·1)
22·9 
(17·3 to 29·4)
23
(19 to 27)
17
(15 to 20)
12
(9 to 15)
–1·4% 
(–3·0 to 0·3)
–3·6% 
(–6·5 to –0·7)
–2·3% 
(–3·6 to –1·0)
Tropical 
Latin America
75·9 
(68·0 to 84·6)
68·3 
(60·9 to 75·6)
60·6 
(47·5 to 75·6)
2818
(2522 to 3139)
2445 
(2182 to 2708)
1969
(1542 to 2457)
–0·8% 
(–1·9 to 0·2)
–1·2% 
(–3·9 to 1·3)
–1·0% 
(–2·2 to 0·1)
Brazil 73·1 
(65·0 to 82·0)
66·0 
(58·4 to 73·7)
58·7 
(45·8 to 73·5)
2609
(2320 to 2925)
2265
(2003 to 2530)
1813
(1414 to 2267)
–0·8% 
(–1·9 to 0·3)
–1·2% 
(–4·0 to 1·4)
–1·0% 
(–2·2 to 0·2)
Paraguay 145·6 
(130·2 to 162·4)
119·8 
(107·3 to 134·0)
95·2 
(71·6 to 126·9)
209
(187 to 233)
181
(162 to 202)
156
(117 to 208)
–1·5% 
(–2·7 to –0·3)
–2·4% 
(–5·3 to 1·0)
–1·9% 
(–3·2 to –0·5)
North Africa 
and Middle East
131·0 
(115·4 to 147·8)
101·8 
(85·1 to 121·3)
78·1 
(63·1 to 97·6)
13 106 
(11 543 to 14 783)
10 370 
(8672 to 12 351)
8907
(7204 to 11 135)
–2·0% 
(–3·2 to –0·9)
–2·7% 
(–4·3 to –1·0)
–2·3% 
(–3·2 to –1·3)
Algeria 126·1 
(87·0 to 170·4)
81·0 
(59·8 to 107·0)
51·5 
(37·2 to 70·1)
949
(655 to 1283)
575
(424 to 759)
470
(340 to 641)
–3·4% 
(–6·5 to 0·1)
–4·5% 
(–8·6 to –0·5)
–3·9% 
(–5·8 to –2·0)
Bahrain 55·4 
(40·7 to 73·4)
32·7
(24·9 to 41·9)
21·4 
(15·5 to 29·0)
7
(5 to 10)
5
(4 to 6)
4
(3 to 6)
–4·0% 
(–6·9 to –1·1)
–4·3% 
(–8·0 to 0·1)
–4·2% 
(–6·1 to –2·2)
Egypt 83·7 
(69·9 to 100·1)
44·8 
(39·1 to 51·9)
32·6 
(24·5 to 42·3)
1385
(1157 to 1656)
765
(668 to 888)
619
(465 to 803)
–4·8% 
(–6·5 to –3·0)
–3·2% 
(–6·2 to –0·3)
–4·1% 
(–5·5 to –2·8)
Iran 40·1 
(27·0 to 57·2)
26·6 
(21·9 to 31·6)
13·5
(9·4 to 18·3)
651
(439 to 929)
333
(275 to 396)
197
(137 to 266)
–3·1% 
(–6·2 to 0·2)
–6·9% 
(–10·9 to –3·1)
–4·7% 
(–7·0 to –2·6)
Iraq 110·6 
(68·7 to 157·0)
88·0 
(62·0 to 126·8)
65·8 
(40·4 to 110·7)
736
(457 to 1045)
816
(574 to 1175)
695
(427 to 1170)
–1·7% 
(–5·6 to 2·5)
–3·1% 
(–8·1 to 2·3)
–2·3% 
(–4·8 to 0·7)
Jordan 102·2 
(79·1 to 128·7)
60·2 
(46·2 to 78·8)
29·8 
(20·3 to 41·4)
112
(87 to 141)
92
(71 to 120)
57
(39 to 79)
–4·1% 
(–6·9 to –1·3)
–7·1% 
(–11·8 to –2·2)
–5·4% 
(–7·2 to –3·5)
Kuwait 17·8 
(14·4 to 21·6)
11·4
(9·6 to 13·6)
9·5
(7·5 to 12·0)
6
(5 to 7)
5
(5 to 7)
7
(5 to 8)
–3·4% 
(–5·4 to –1·4)
–1·8% 
(–4·4 to 0·8)
–2·7% 
(–4·0 to –1·4)
Lebanon 101·4 
(74·8 to 135·1)
42·4 
(30·8 to 56·8)
18·1 
(11·9 to 26·0)
65
(48 to 87)
23
(16 to 30)
12
(8 to 17)
–6·7% 
(–9·5 to –3·9)
–8·6% 
(–12·7 to –4·9)
–7·5% 
(–9·7 to –5·5)
Libya 41·8 
(25·7 to 64·6)
30·7
(22·8 to 40·5)
27·0 
(18·0 to 40·5)
46
(28 to 71)
37
(27 to 49)
33
(22 to 50)
–2·3% 
(–6·0 to 1·6)
–1·4% 
(–6·5 to 3·7)
–1·9% 
(–4·5 to 0·8)
Morocco 279·5 
(236·0 to 338·9)
98·3 
(75·2 to 120·8)
63·9 
(45·1 to 85·8)
1971
(1664 to 2390)
603
(462 to 741)
472
(334 to 635)
–8·1% 
(–10·2 to –6·0)
–4·4% 
(–7·5 to –1·3)
–6·5% 
(–8·1 to –5·0)
Oman 47·0 
(26·7 to 76·6)
20·4 
(14·2 to 29·4)
12·8
(8·4 to 20·6)
30
(17 to 49)
11
(7 to 15)
9
(6 to 15)
–6·3% 
(–10·8 to –1·7)
–4·8% 
(–10·8 to 1·2)
–5·6% 
(–8·5 to –2·8)
Palestine 21·1 
(12·3 to 34·3)
11·3
(8·7 to 14·4)
9·0
(5·5 to 13·2)
22
(13 to 35)
13
(10 to 17)
12
(7 to 17)
–4·6% 
(–9·0 to –0·4)
–2·5% 
(–7·5 to 2·3)
–3·7% 
(–6·8 to –0·7)
(Table 1 continues on next page)
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Qatar 50·4 
(36·2 to 69·8)
38·9 
(29·6 to 50·1)
18·7 
(12·4 to 27·2)
5
(4 to 7)
4
(3 to 6)
4
(3 to 6)
–2·0% 
(–5·1 to 1·0)
–7·4% 
(–12·2 to –2·8)
–4·3% 
(–6·6 to –2·2)
Saudi Arabia 15·7
(9·1 to 25·2)
9·3
(7·6 to 11·1)
7·0
(5·2 to 9·2)
88
(51 to 140)
49
(41 to 59)
38
(28 to 50)
–3·8% 
(–7·9 to 0·6)
–2·8% 
(–6·2 to 0·5)
–3·4% 
(–5·8 to –0·8)
Sudan 407·8 
(304·2 to 502·9)
356·5 
(237·6 to 478·8)
275·2 
(181·1 to 377·5)
3558
(2654 to 4388)
4193 
(2794 to 5631)
3528 
(2322 to 4840)
–1·1% 
(–3·5 to 1·1)
–2·6% 
(–5·4 to 0·2)
–1·8% 
(–3·3 to –0·2)
Syria 120·5 
(86·0 to 158·8)
64·8 
(49·1 to 80·9)
44·1 
(31·1 to 60·3)
513
(367 to 676)
309
(235 to 386)
229
(161 to 313)
–4·7% 
(–7·7 to –1·8)
–3·9% 
(–7·7 to 0·1)
–4·4% 
(–6·4 to –2·4)
Tunisia 62·2
(44·4 to 82·7)
28·5
(18·4 to 42·3)
19·0
(11·6 to 28·5)
124
(88 to 164)
48
(31 to 72)
35
(21 to 53)
–6·1%
(–9·7 to –2·4)
–4·1%
(–9·1 to 0·7)
–5·2%
(–7·6 to –3·0)
Turkey 48·5 
(34·7 to 65·2)
23·1
(17·1 to 30·9)
15·0 
(10·7 to 19·9)
664
(475 to 893)
304
(226 to 408)
188
(134 to 250)
–5·7% 
(–8·9 to –2·6)
–4·3% 
(–8·4 to –0·1)
–5·1% 
(–6·9 to –3·2)
United 
Arab Emirates
55·8 
(31·0 to 112·1)
21·6
(14·1 to 33·7)
12·8
(7·7 to 21·4)
23
(13 to 47)
12
(8 to 18)
17
(10 to 29)
–7·1% 
(–11·9 to –2·4)
–5·3% 
(–10·2 to 1·0)
–6·3% 
(–9·5 to –3·0)
Yemen 342·6 
(182·1 to 519·2)
322·2 
(182·7 to 524·9)
308·8 
(168·6 to 555·4)
2151
(1143 to 3260)
2172
(1232 to 3538)
2279 
(1244 to 4099)
–0·5% 
(–3·5 to 2·7)
–0·5% 
(–3·8 to 3·3)
–0·5% 
(–2·8 to 2·2)
High-income 
North America
11·9 
(10·7 to 13·3)
17·0
(15·1 to 18·8)
17·6 
(14·3 to 21·6)
555
(499 to 621)
784
(697 to 867)
829
(672 to 1016)
2·7% 
(1·5 to 3·8)
0·3% 
(–1·8 to 2·6)
1·7% 
(0·7 to 2·6)
Canada 7·1
(6·0 to 8·3)
9·2
(7·6 to 10·7)
8·2
(6·3 to 10·3)
28
(24 to 33)
32
(27 to 37)
33
(25 to 42)
2·0% 
(0·2 to 3·6)
–1·2% 
(–3·7 to 1·3)
0·6% 
(–0·7 to 1·9)
USA 12·4 
(11·1 to 13·9)
17·6
(15·7 to 19·5)
18·5 
(14·8 to 22·9)
527
(472 to 592)
752
(669 to 833)
796
(638 to 985)
2·7% 
(1·4 to 3·8)
0·5% 
(–1·8 to 2·8)
1·7% 
(0·8 to 2·7)
Oceania 599·9 
(365·3 to 972·5)
577·8 
(331·4 to 976·3)
494·1 
(264·4 to 849·3)
1234
(752 to 2001)
1461
(838 to 2469)
1325
(709 to 2278)
–0·3% 
(–3·3 to 2·7)
–1·6% 
(–5·2 to 2·4)
–0·9% 
(–3·2 to 1·7)
Federated 
States of 
Micronesia
170·3 
(82·9 to 310·8)
130·5 
(66·6 to 235·5)
87·9 
(44·7 to 154·5)
6
(3 to 10)
4
(2 to 7)
2
(1 to 4)
–2·0% 
(–6·0 to 2·0)
–3·9% 
(–8·5 to 0·7)
–2·9% 
(–5·6 to 0·0)
Fiji 109·6 
(68·4 to 165·2)
100·8 
(72·0 to 135·5)
68·2 
(43·7 to 102·8)
24
(15 to 36)
19
(14 to 26)
12
(8 to 18)
–0·6% 
(–4·4 to 3·6)
–4·0% 
(–9·0 to 0·8)
–2·1% 
(–4·9 to 0·7)
Kiribati 213·3 
(153·9 to 296·9)
142·4 
(97·1 to 216·5)
100·9 
(57·4 to 169·1)
6
(4 to 8)
3
(2 to 5)
2
 (1 to 4)
–3·2% 
(–7·1 to 0·8)
–3·6% 
(–9·0 to 1·8)
–3·4% 
(–6·2 to –0·6)
Marshall 
Islands
74·7 
(46·2 to 111·8)
109·4 
(66·3 to 167·8)
95·6 
(51·9 to 164·9)
2
(1 to 2)
2
(1 to 3)
2
(1 to 3)
2·9% 
(–1·6 to 7·4)
–1·5% 
(–7·8 to 5·1)
1·0% 
(–2·0 to 4·0)
Papua 
New Guinea
765·9 
(456·7 to 1255·9)
702·6 
(396·4 to 1197·8)
594·2 
(312·7 to 1030·8)
1148
(684 to 1882)
1382
(779 to 2355)
1260
(663 to 2187)
–0·7% 
(–3·8 to 2·4)
–1·7% 
(–5·4 to 2·3)
–1·1% 
(–3·6 to 1·5)
Samoa 61·1 
(36·2 to 99·7)
51·2
(32·5 to 76·3)
41·4 
(26·9 to 62·8)
3
(2 to 5)
3
(2 to 4)
2
(1 to 3)
–1·3% 
(–6·0 to 3·3)
–2·1% 
(–7·0 to 3·3)
–1·6% 
(–4·6 to 1·1)
Solomon 
Islands
254·0 
(127·4 to 454·4)
214·5 
(112·5 to 379·3)
183·0 
(95·9 to 338·5)
32
(16 to 56)
34
(18 to 60)
32
(17 to 59)
–1·3% 
(–5·2 to 2·7)
–1·6% 
(–6·0 to 3·2)
–1·4% 
(–4·5 to 1·6)
Tonga 188·1 
(118·8 to 286·9)
143·3 
(108·8 to 185·6)
111·2 
(68·2 to 172·2)
6
(4 to 9)
4
(3 to 5)
3
(2 to 5)
–2·0% 
(–6·0 to 1·8)
–2·7% 
(–7·8 to 2·3)
–2·3% 
(–5·0 to 0·4)
Vanuatu 176·3 
(83·5 to 329·7)
174·8 
(88·2 to 333·0)
139·2 
(72·3 to 257·6)
10
(5 to 18)
10
(5 to 20)
9
(5 to 17)
–0·1% 
(–4·2 to 4·1)
–2·2% 
(–6·6 to 2·4)
–1·0% 
(–4·0 to 2·2)
Central sub-
Saharan Africa
456·3 
(366·2 to 546·7)
419·1 
(341·2 to 499·8)
353·1 
(279·9 to 434·1)
12 178
(9773 to 14 591)
15 191
(12 369 to 18 118)
15 355
(12 174 to 18 880)
–0·7% 
(–2·2 to 0·8)
–1·7% 
(–3·8 to 0·3)
–1·1% 
(–2·3 to 0·1)
Angola 510·6 
(324·9 to 747·3)
451·1 
(308·9 to 657·8)
310·1 
(198·3 to 472·2)
2976
(1894 to 4356)
3672
(2515 to 5355)
3032
(1939 to 4618)
–0·9% 
(–3·7 to 1·8)
–3·8% 
(–7·1 to –0·5)
–2·2% 
(–4·0 to 0·0)
Central 
African 
Republic
788·7 
(576·4 to 1020·1)
999·4 
(636·2 to 1415·6)
910·5 
(578·3 to 1293·2)
973
(711 to 1258)
1473
(937 to 2086)
1459
(926 to 2072)
1·8% 
(–0·7 to 3·9)
–0·9% 
(–3·8 to 1·7)
0·6% 
(–1·0 to 2·0)
Congo 397·2 
(275·6 to 545·1)
482·8 
(322·1 to 673·7)
287·3 
(189·6 to 427·1)
379
(263 to 519)
678
(452 to 946)
494
(326 to 735)
1·5% 
(–1·1 to 3·9)
–5·2% 
(–8·5 to –2·0)
–1·4% 
(–3·4 to 0·4)
DR Congo 420·1 
(323·5 to 521·5)
369·5 
(295·0 to 451·4)
342·3 
(251·4 to 446·7)
7616
(5865 to 9455)
9069
(7241 to 11 081)
10 125
(7437 to 13 213)
–1·0% 
(–3·1 to 1·3)
–0·8% 
(–3·7 to 1·8)
–0·9% 
(–2·6 to 0·7)
Equatorial 
Guinea
599·9 
(376·2 to 897·0)
487·3 
(280·4 to 736·7)
369·6 
(199·8 to 620·0)
109
(68 to 163)
110
(63 to 166)
100
(54 to 168)
–1·6% 
(–5·4 to 2·3)
–2·9% 
(–6·9 to 1·4)
–2·2% 
(–4·9 to 0·9)
(Table 1 continues on next page)
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Maternal mortality ratio (per 100 000 livebirths) Number of maternal deaths Annualised rate of change in maternal 
mortality ratio (%)
1990 2003 2013 1990 2003 2013 1990–2003 2003–13 1990–2013
(Continued from previous page)
Gabon 345·7 
(265·2 to 438·6)
413·0 
(301·0 to 541·8)
267·3 
(184·1 to 370·3)
126
(96 to 159)
189
(138 to 248)
144
(99 to 199)
1·3% 
(–1·3 to 4·0)
–4·4% 
(–7·9 to –1·3)
–1·2% 
(–2·9 to 0·6)
Eastern sub-
Saharan Africa
511·7
(461·5 to 562·3)
564·7
(490·8 to 640·0)
387·2
(331·5 to 453·0)
45 250
(40 808 to 49 719)
65 050
(56 537 to 73 735)
52 269
(44 747 to 61 144)
0·7%
(–0·3 to 1·9)
–3·8%
(–5·1 to –2·4)
–1·2%
(–1·8 to –0·6)
Burundi 757·1 
(560·5 to 977·3)
712·3 
(538·5 to 899·9)
370·8 
(240·4 to 504·3)
2122
(1571 to 2739)
2240
(1693 to 2830)
1683
(1091 to 2289)
–0·5% 
(–3·0 to 1·9)
–6·6% 
(–10·2 to –3·7)
–3·1% 
(–5·1 to –1·4)
Comoros 527·4 
(319·7 to 830·5)
383·0 
(219·8 to 646·7)
329·2 
(171·9 to 584·5)
82
(50 to 130)
88
(50 to 148)
85
(45 to 152)
–2·5% 
(–6·0 to 1·1)
–1·7% 
(–6·6 to 2·6)
–2·2% 
(–4·9 to 0·7)
Djibouti 526·3 
(334·8 to 788·7)
629·3 
(405·3 to 962·4)
523·5 
(329·8 to 821·8)
124
(79 to 186)
138
(89 to 211)
123
(77 to 193)
1·4% 
(–1·9 to 4·6)
–1·9% 
(–5·2 to 1·5)
0·0% 
(–2·2 to 2·2)
Eritrea 614·2 
(493·7 to 747·0)
679·9 
(475·9 to 902·1)
566·0 
(351·2 to 817·7)
949
(763 to 1154)
1241
(868 to 1646)
1313
(814 to 1896)
0·7% 
(–1·8 to 3·1)
–1·9% 
(–5·1 to 0·9)
–0·4% 
(–2·3 to 1·3)
Ethiopia 708·0 
(600·4 to 815·0)
657·8 
(486·3 to 839·6)
497·4 
(371·5 to 648·8)
16 740
(14 197 to 19 271)
18 941
(14 001 to 24 173)
15 234
(11 378 to 19 871)
–0·6% 
(–3·1 to 1·4)
–2·8% 
(–5·2 to –0·2)
–1·6% 
(–2·8 to –0·3)
Kenya 315·5 
(250·1 to 382·2)
559·2 
(375·0 to 773·0)
277·2 
(175·4 to 414·1)
3047
(2416 to 3692)
7628
(5115 to 10 543)
4361
(2759 to 6514)
4·3% 
(1·3 to 7·4)
–7·1% 
(–10·8 to –3·9)
–0·6% 
(–2·6 to 1·4)
Madagascar 314·0 
(246·9 to 375·5)
378·0 
(255·9 to 480·7)
297·7 
(174·3 to 448·6)
1723
(1355 to 2061)
2610
(1766 to 3319)
2455
(1438 to 3699)
1·4% 
(–1·0 to 3·4)
–2·6% 
(–6·4 to 1·6)
–0·3% 
(–2·3 to 1·5)
Malawi 550·3 
(440·5 to 669·6)
815·3 
(567·4 to 1111·1)
334·7 
(224·5 to 465·1)
2627
(2103 to 3197)
4542
(3161 to 6189)
2260
(1516 to 3140)
3·0% 
(0·7 to 5·3)
–8·9% 
(–12·5 to –6·1)
–2·2% 
(–3·8 to –0·6)
Mauritius 66·8 
(56·8 to 79·1)
55·9
(47·8 to 65·8)
43·7 
(34·4 to 54·7)
15
(13 to 18)
10
(8 to 12)
6
(5 to 8)
–1·4% 
(–3·0 to 0·4)
–2·5% 
(–5·1 to 0·0)
–1·9% 
(–3·0 to –0·6)
Mozambique 363·4 
(262·6 to 463·2)
250·0 
(184·3 to 322·0)
248·7 
(151·4 to 365·4)
2190
(1583 to 2791)
2339
(1724 to 3012)
2574
(1567 to 3783)
–2·9% 
(–5·7 to 0·2)
–0·2% 
(–3·9 to 3·0)
–1·7% 
(–4·0 to 0·5)
Rwanda 656·1 
(528·6 to 791·5)
612·6 
(477·4 to 766·5)
291·0 
(189·9 to 400·7)
2021
(1628 to 2438)
2142 
(1669 to 2680)
1185
(773 to 1631)
–0·5% 
(–2·6 to 1·6)
–7·6% 
(–11·6 to –4·0)
–3·6% 
(–5·6 to –1·9)
Seychelles 21·2 
(16·4 to 26·7)
14·9
(11·6 to 18·9)
15·7
(12·2 to 20·7)
0
(0 to 0)
0
(0 to 0)
0
(0 to 0)
–2·7% 
(–5·0 to –0·2)
0·5% 
(–2·8 to 4·0)
–1·3% 
(–2·8 to 0·3)
Somalia 486·9 
(276·2 to 766·6)
422·4 
(264·4 to 706·2)
407·7 
(247·4 to 684·2)
1574
(893 to 2479)
1673
(1047 to 2797)
1903
(1155 to 3194)
–1·1% 
(–4·2 to 1·9)
–0·4% 
(–3·5 to 2·9)
–0·8% 
(–2·8 to 1·6)
South Sudan 763·8 
(432·8 to 1129·7)
872·9 
(602·8 to 1172·3)
956·8 
(685·1 to 1262·8)
2138
(1211 to 3162)
2718
(1877 to 3650)
3912
(2801 to 5163)
1·2% 
(–2·3 to 4·9)
0·9% 
(–2·5 to 4·8)
1·1% 
(–1·2 to 3·8)
Tanzania 498·0 
(399·2 to 593·4)
622·9 
(449·6 to 812·0)
389·6 
(266·5 to 548·7)
5814
(4661 to 6929)
10 148
(7324 to 13 228)
7745
(5298 to 10 908)
1·7% 
(–0·7 to 3·9)
–4·7% 
(–7·9 to –1·7)
–1·1% 
(–2·7 to 0·4)
Uganda 296·3 
(215·6 to 392·4)
461·5 
(319·6 to 615·9)
324·9 
(213·8 to 450·2)
2800
(2037 to 3708)
6159
(4265 to 8219)
5385
(3544 to 7461)
3·4% 
(1·0 to 5·9)
–3·5% 
(–6·6 to –0·6)
0·4% 
(–1·4 to 2·2)
Zambia 354·6 
(256·2 to 464·3)
475·1 
(301·7 to 697·1)
315·1 
(206·7 to 459·3)
1283
(927 to 1679)
2435
(1547 to 3574)
2044
(1341 to 2980)
2·2% 
(–0·5 to 4·5)
–4·1% 
(–7·3 to –0·7)
–0·6% 
(–2·1 to 1·0)
Southern sub-
Saharan Africa
150·8 
(115·9 to 182·6)
490·4 
(367·8 to 626·1)
279·8 
(202·6 to 381·5)
2455
(1886 to 2973)
8406
(6305 to 10 733)
4898
(3547 to 6679)
9·1% 
(6·5 to 11·8)
–5·6% 
(–8·1 to –3·0)
2·7% 
(1·2 to 4·4)
Botswana 205·8 
(101·3 to 325·6)
1061·1 
(523·3 to 1793·6)
480·8 
(211·8 to 828·4)
95
(47 to 151)
504
(249 to 852)
228
(100 to 393)
12·6% 
(6·9 to 18·0)
–8·1% 
(–12·5 to –3·7)
3·6% 
(–0·1 to 6·7)
Lesotho 189·5 
(130·9 to 255·2)
606·5 
(419·2 to 849·2)
510·6 
(303·5 to 772·7)
107
(74 to 144)
343
(237 to 480)
295
(175 to 446)
8·9% 
(5·5 to 12·7)
–1·8% 
(–5·1 to 1·5)
4·3% 
(1·9 to 6·6)
Namibia 165·2 
(99·1 to 223·4)
307·5 
(212·4 to 440·0)
149·6 
(90·3 to 236·1)
89
(54 to 121)
184
(127 to 263)
89
(54 to 141)
4·8% 
(1·5 to 8·5)
–7·3% 
(–11·5 to –3·3)
–0·5% 
(–2·6 to 1·6)
South Africa 134·0 
(93·3 to 175·2)
341·8 
(227·8 to 481·0)
174·1 
(96·3 to 274·9)
1403
(977 to 1835)
3739
(2492 to 5262)
1925
(1065 to 3041)
7·2% 
(3·3 to 11·1)
–6·9% 
(–11·1 to –2·7)
1·0% 
(–1·6 to 3·8)
Swaziland 111·2
(78·1 to 151·1)
272·9
(191·9 to 385·2)
148·5
(91·1 to 229·1)
41
(29 to 56)
97
(68 to 137)
55
(34 to 85)
6·9% 
(3·2 to 10·5)
–6·2% 
(–10·1 to –2·2)
1·2% 
(–1·3 to 3·6)
Zimbabwe 185·8 
(143·8 to 232·9)
840·9 
(490·4 to 1238·2)
520·7 
(313·5 to 786·2)
719
(556 to 901)
3539
(2064 to 5212)
2306
(1388 to 3481)
11·5% 
(8·3 to 14·4)
–4·8% 
(–8·3 to –1·4)
4·4% 
(2·6 to 6·3)
Western sub-
Saharan Africa
480·4 
(419·0 to 544·8)
563·3 
(489·7 to 639·1)
468·9 
(385·4 to 564·0)
44 133
(38 493 to 50 052)
69 443
(60 370 to 78 794)
70 858
(58 231 to 85 221)
1·2% 
(–0·2 to 2·6)
–1·9% 
(–3·3 to –0·3)
–0·1% 
(–1·1 to 0·8)
Benin 523·5 
(418·4 to 619·6)
415·8 
(311·4 to 522·8)
328·6 
(229·2 to 441·3)
1259
(1006 to 1490)
1347
(1009 to 1694)
1246
(869 to 1674)
–1·8% 
(–4·1 to 0·5)
–2·4% 
(–5·2 to 0·2)
–2·1% 
(–3·6 to –0·6)
(Table 1 continues on next page)
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annualised rate of change from 2003 to 2013 to predict 
the MMR for 2030. For countries with an increasing 
MMR in that period, we assumed that the MMR would 
remain constant. We used UN Population Division 
forecasts of the population aged 15–49 years and births 
to forecast the number of maternal deaths for each 
country. We calculated annualised rate of change for 
1990–2013 using the continuous rate-of-change formula. 
Achievement of the MDG 5 target would be equivalent 
to a sustained 5·5% decrease per year from 1990 to 2015.
Uncertainty
We report 95% uncertainty intervals (UIs) for maternal 
deaths, the MMR, causes of maternal death, timing of 
maternal deaths, and annualised rates of change. The 
ensemble models for maternal mortality generate 
1000 draws from the posterior distribution; the validity 
of the UIs was conﬁ rmed through 50 iterations of cross-
validation with data held out during CODEm estimation. 
Additionally, DisMod-MR produced 1000 draws from the 
posterior distribution for the cause analysis and time-of-
death analysis. We assumed uncertainty in the estimated 
fraction of maternal deaths due to each cause or the 
estimated fraction of maternal deaths in diﬀ erent 
timings to be independent of the uncertainty in the 
occurrence of maternal mortality. We calculated 
uncertainty with 1000 draws from the posterior 
distribution of every step of the estimation process, 
which allows for quantiﬁ cation and propagation of 
uncertainty associated with each of the epidemiological 
variables in the GBD framework. These UIs are diﬀ erent 
from conﬁ dence intervals, which would only quantify 
Maternal mortality ratio (per 100 000 livebirths) Number of maternal deaths Annualised rate of change in maternal 
mortality ratio (%)
1990 2003 2013 1990 2003 2013 1990–2003 2003–13 1990–2013
(Continued from previous page)
Burkina Faso 301·5 
(224·9 to 383·1)
409·2 
(307·2 to 517·5)
310·5 
(223·1 to 406·2)
1325
(989 to 1684)
2443
(1834 to 3090)
2185
(1570 to 2858)
2·3% 
(0·1 to 4·6)
–2·8% 
(–6·1 to 0·3)
0·1% 
(–1·5 to 1·6)
Cameroon 436·4 
(351·7 to 510·0)
614·4 
(472·3 to 789·3)
564·6 
(414·0 to 743·6)
2451
(1975 to 2865)
4476
(3441 to 5750)
4772
(3499 to 6285)
2·6% 
(0·5 to 5·0)
–0·9% 
(–3·4 to 1·4)
1·1% 
(–0·4 to 2·6)
Cape Verde 110·4 
(83·5 to 138·3)
80·5 
(47·8 to 128·1)
47·6 
(27·9 to 76·2)
15
(11 to 19)
9
(5 to 15)
5
(3 to 8)
–2·6% 
(–6·6 to 1·2)
–5·3% 
(–11·2 to 0·4)
–3·8% 
(–6·2 to –1·4)
Chad 429·8 
(352·9 to 510·2)
659·2 
(506·9 to 808·4)
597·6 
(408·4 to 809·5)
1424
(1170 to 1691)
3245
(2496 to 3980)
3593
(2456 to 4868)
3·3% 
(1·3 to 5·3)
–1·1% 
(–3·8 to 1·3)
1·4% 
(–0·3 to 2·9)
Côte d’Ivoire 496·9 
(374·7 to 606·4)
729·8 
(521·8 to 968·7)
501·5 
(354·3 to 653·9)
2539
(1915 to 3099)
4771
(3411 to 6333)
3824
(2702 to 4987)
2·9% 
(0·5 to 5·2)
–3·7% 
(–6·8 to –0·9)
0·0% 
(–1·4 to 1·3)
Ghana 374·3 
(247·7 to 528·1)
418·1 
(309·6 to 532·9)
293·4 
(193·5 to 410·4)
2143
(1418 to 3024)
2933
(2172 to 3739)
2343
(1545 to 3277)
0·9% 
(–2·6 to 4·7)
–3·6% 
(–7·3 to –0·3)
–1·1% 
(–3·6 to 1·4)
Guinea 660·4 
(564·4 to 768·8)
676·3 
(542·1 to 811·8)
615·4 
(470·5 to 781·9)
1966
(1680 to 2289)
2642
(2118 to 3171)
2720
(2080 to 3457)
0·2% 
(–1·7 to 1·8)
–1·0% 
(–3·1 to 1·0)
–0·3% 
(–1·6 to 0·9)
Guinea-
Bissau
708·1 
(417·3 to 1052·9)
837·7 
(573·6 to 1154·5)
885·3 
(616·5 to 1230·2)
334
(197 to 497)
478
(327 to 659)
576
(401 to 800)
1·4% 
(–1·6 to 4·5)
0·6% 
(–2·3 to 3·5)
1·0% 
(–1·0 to 3·0)
Liberia 630·1 
(487·9 to 782·0)
779·5 
(605·3 to 962·1)
627·3 
(467·5 to 793·2)
624
(483 to 775)
1038
(806 to 1281)
974
(726 to 1232)
1·6% 
(–0·8 to 4·1)
–2·2% 
(–4·6 to 0·1)
0·0% 
(–1·6 to 1·4)
Mali 573·0 
(500·0 to 649·8)
506·7 
(415·9 to 603·8)
388·3 
(300·6 to 487·3)
2326
(2030 to 2638)
2936
(2410 to 3499)
2966
(2295 to 3722)
–1·0% 
(–2·5 to 0·7)
–2·7% 
(–5·0 to –0·5)
–1·7% 
(–2·9 to –0·5)
Mauritania 680·6 
(585·6 to 789·8)
681·0 
(501·2 to 856·1)
568·8 
(363·6 to 793·6)
580
(499 to 673)
772
(568 to 971)
761
(487 to 1062)
0·0% 
(–2·4 to 1·8)
–1·9% 
(–4·6 to 0·6)
–0·8% 
(–2·7 to 0·7)
Niger 481·0 
(394·4 to 567·6)
427·3 
(348·3 to 523·0)
406·5 
(308·2 to 505·0)
2217
(1818 to 2616)
2920
(2379 to 3573)
3873
(2936 to 4811)
–0·9% 
(–2·7 to 0·9)
–0·5% 
(–2·9 to 1·7)
–0·7% 
(–2·1 to 0·5)
Nigeria 483·2 
(359·9 to 608·4)
585·7 
(445·6 to 717·8)
496·4 
(335·9 to 666·2)
21 233
(15 814 to 26 737)
34 810
(26 480 to 42 656)
36 698
(24 829 to 49 252)
1·5% 
(–1·2 to 4·0)
–1·7% 
(–4·4 to 0·9)
0·1% 
(–1·8 to 1·9)
São Tomé and 
Príncipe
297·5 
(211·4 to 395·6)
195·7 
(133·1 to 251·6)
134·9 
(65·2 to 208·6)
13
(9 to 18)
11
(8 to 14)
9
(4 to 14)
–3·2% 
(–6·6 to –0·1)
–4·0% 
(–9·5 to 0·9)
–3·6% 
(–6·5 to –1·0)
Senegal 518·8
(441·9 to 601·7)
462·2
(366·1 to 557·3)
347·2
(249·2 to 455·2)
1727
(1471 to 2003)
2018
(1598 to 2433)
1881
(1350 to 2466)
–0·9% 
(–2·9 to 0·9)
–2·9% 
(–5·5 to –0·5)
–1·8% 
(–3·2 to –0·5)
Sierra Leone 521·4
(383·9 to 668·2)
665·1
(535·3 to 795·8)
622·6
(447·9 to 790·5)
943
(694 to 1209)
1360
(1095 to 1627)
1399
(1006 to 1776)
1·9% 
(–0·6 to 4·3)
–0·7% 
(–3·4 to 1·6)
0·8% 
(–1·0 to 2·3)
The Gambia 444·4
(230·1 to 685·5)
368·2
(191·4 to 580·8)
264·5
(135·5 to 434·7)
205
(106 to 316)
232
(121 to 366)
216
(111 to 356)
–1·4% 
(–5·0 to 2·4)
–3·3% 
(–6·9 to 0·6)
–2·2% 
(–5·0 to 0·6)
Togo 496·7 
(407·1 to 603·8)
477·4 
(332·4 to 644·0)
326·2 
(210·7 to 473·0)
807
(662 to 981)
1001
(697 to 1350)
817
(528 to 1185)
–0·4% 
(–3·1 to 2·2)
–3·9% 
(–7·4 to –0·4)
–1·9% 
(–3·8 to –0·1)
Data in parentheses are 95% uncertainty intervals.
Table 1: Maternal mortality ratio, numbers of maternal deaths, and annualised rates of change for 21 Global Burden of Disease regions and 188 countries
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speciﬁ c model.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The authors had access to the data in the 
study and had ﬁ nal responsibility for the decision to 
submit for publication.
Results
The total annual number of maternal deaths decreased 
from 376 034 (95% UI 343 483– 407 574) in 1990, to 292 982 
(261 017–327 792) in 2013 (ﬁ gure 3A, table 1). The 
reduction accelerated steadily from 1990 to 2013 
(ﬁ gure 3B), with corresponding decreases in MMR 
(table 1). Between 2003 and 2013, the annual rate of 
change in MMR was greater than –1%, reaching –3·3% 
for 2012–13 (ﬁ gure 3B).
MMR was highest in the oldest age groups and lowest 
in women aged 20–29 years in both 1990 and 2013 
(ﬁ gure 4). However, it decreased signiﬁ cantly between 
1990 and 2013 for almost all age groups (ﬁ gure 4). We 
used data for the proportions of births in diﬀ erent 
maternal age groups and calculated that 9·5% of 
maternal deaths are in the group aged 15–19 years, 
43·1% in women aged 20–29 years, and 47·0% in those 
aged 30 years and older, with the remainder occurring 
in the group aged 10–14 years. Despite much higher 
rates of mortality in older age groups, the total number 
of deaths is roughly equal before and after the age of 
30 years. The MMR in mothers aged 15–19 years in 2013 
was 1·5 times higher than that in women aged 
20–24 years, and 1·4 times higher than in those aged 
25–29 years. In 2013, the MMR was 9·5 times higher for 
a woman aged 45–49 years (1374·4, 95% UI 
1117·1–1694·9) than for a woman aged 20–24 years 
(144·1, 120·6–169·9). 
We recorded substantial diﬀ erences across the GBD 
regions in the trends in maternal deaths and the MMR 
(ﬁ gure 5). Of the regions where the MMR was more than 
300 in 1990, south Asia made the greatest progress by 
2013 (ﬁ gure 5A, table 1). In eastern and western sub-
Saharan Africa, MMRs increased until 2005, but have 
since reduced substantially (ﬁ gure 5A). The MMR in 
eastern sub-Saharan Africa has been changing at a rate of 
–4·5% per year (95% UI –6·0 to –2·8) since 2005.
Of regions that had MMRs of 100–300 in 1990, southeast 
Asia has had the most notable decreases (ﬁ gure 5B). The 
MMR in the Caribbean has followed a similar trend to 
eastern and western sub-Saharan Africa—ie, increasing 
to 2005, before falling—and it has improved only slightly 
in north Africa and the Middle East (ﬁ gure 5B). The 
MMR in southern sub-Saharan Africa increased greatly 
between 1990 and 2006, rising from 150·8 (95% UI 
115·9–182·6) to 565·7 (420·1–737·2), but then fell to 
279·8 (202·6–381·5) in 2013 (ﬁ gure 5B).
We recorded decreases in MMRs in all regions that had 
an MMR of 30–100 in 1990 (ﬁ gure 5C, table 1). This 
reduction is particularly evident in east Asia (ﬁ gure 5C, 
table 1). The rates of change in southern Latin America 
and central Latin America since 2000 seem to have been 
slower than those before 2000 (ﬁ gure 5C). In regions 
with low MMR in 1990 (<30), the MMR has continued to 
reduce slowly, except for in the high-income region of 
North America (ﬁ gure 5D, table 1).
Except for late maternal deaths and HIV-related deaths, 
the absolute numbers of deaths due to every cause 
decreased signiﬁ cantly (p<0·001) from 1990 to 2013 
(table 2, appendix). However, in sub-Saharan Africa, the 
number of deaths due to all causes increased from 1990 
to 2013 (table 1). Globally, the biggest absolute reduction 
was in deaths due to maternal haemorrhage: from 71 295 
(95% UI 64 562–78 329) in 1990, to 44 190 (38 273–50 819) 
in 2013. The biggest percentage decrease was in maternal 
sepsis, which caused 11·6% (11·4–11·8) of all maternal 
deaths in 1990, but 9·7% (9·5–9·9) in 2013 (ﬁ gure 6A). 
The proportion of maternal deaths due to indirect causes 
increased slightly from 9·1% (95% UI 8·9–9·4) in 1990, 
to 10·2% (10·0–10·5) in 2013 (ﬁ gure 6A). Additionally, 
the proportion of maternal deaths due to other direct 
causes rose from 16·5% (95% UI 16·3–16·8) in 1990, to 
17·0% (16·7–17·3) in 2013 (ﬁ gure 6A). The number of 
late maternal deaths decreased globally by 3·0%, from 
44 814 (95% UI 36 414–53 106) in 1990, to 43 507 
(35 667–52 395) deaths in 2013. In 2013, HIV accounted 
for 1·5% (0·9–2·0) of all maternal deaths in sub-Saharan 
Africa, but only 0·4% (0·2–0·6) worldwide. The number 
of abortion-related deaths decreased signiﬁ cantly at the 
global level (p=0·002; ﬁ gure 6A) and in all regions other 
than Oceania, where no signiﬁ cant change occurred 
(p=0·35), and sub-Saharan Africa, where the number of 
deaths increased signiﬁ cantly after abortion (p<0·001).
Figure 4: Global maternal mortality ratio in 1990 and 2013, by age
Shaded areas show 95% uncertainty intervals.
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Cause patterns vary by regions. The two most 
important causes of maternal death in high-income 
regions in 2013 were indirect and other direct causes 
(ﬁ gure 6B), owing largely to a decrease in abortion-
related deaths, which was the most important cause of 
maternal mortality in high-income regions in 1990. The 
number of deaths due to haemorrhage, hypertension, 
and maternal sepsis  have also decreased signiﬁ cantly, 
whereas the numbers of deaths due to indirect and late 
maternal causes have increased since 1990 (ﬁ gure 6B, 
appendix). By contrast, the most important causes in 
low-income countries—other direct, abortion, and 
haemorrhage—have not changed between 1990 and 
2013, although diﬀ erent trends are apparent in diﬀ erent 
regions. For example, east Asia had signiﬁ cant 
decreases in all causes except HIV (which was estimated 
to be the cause of 0·003% of all maternal deaths in 
2013; appendix). The total global number of HIV-related 
maternal deaths in 2013 was 2070 (95% UI 1290–2866), 
reduced from a peak of 3280 (2041–4403) in 2004. The 
increase in proportion of deaths due to indirect 
maternal causes was most notable in Latin America 
and the Caribbean, where the proportion increased 
from 9·2% (95% UI 8·8–9·8) in 1990, to 11·5% 
(10·9–12·2) in 2013.
In 2013, on average, nearly a quarter of deaths occurred 
antepartum (24·6%, 24·1–25·2), a quarter intrapartum 
and immediately postpartum (27·7%, 27·1–28·2), a third 
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Figure 5: Change in MMR between 1990 and 2013, by region
MMR=maternal mortality ratio.
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subacute and delayed postpartum (35·6%, 34·9–36·2), 
and 12·1% (11·9–12·5) late. The biggest absolute change 
was in intrapartum deaths (table 2, appendix), which 
decreased by more than 35%, but equally notable was that 
despite a decrease in the mean fraction of postpartum 
deaths, the proportion of total deaths occurring 
postpartum and late actually increased at the global level 
(p<0·001).
Cause of death Timing of death
Abortion Haem-
orrhage
Hyper-
tension
Obstructed 
labour
Sepsis Late Other 
direct
Indirect HIV Ante-
partum
Intra-
partum*
Postpartum† Late
Worldwide 43 684 
(38 336–
49 843)
44 190 
(38 275–
50 819)
29 275 
(25 664–
33 376)
18 789 
(16 281–
21 747)
23 717 
(20 045–
27 993)
43 507 
(35 667–
52 395)
56 114 
(48 671–
64 245)
31 058 
(26 818–
35 679)
2070 
(1290–
2866)
61 176 
(52 959–
70 010)
64 823 
(55 562–
74 856)
123 476 
(109 051–
139 584)
43 507 
(35 667–
52 395)
Andean 
Latin America
160
(115–215)
165
(126–211)
174 
(131–217)
64
(46–84)
128 
(98–163)
260 
(194–331)
125 
(95–158)
85
(65–109)
0
(0–0)
154
(114–204)
285
(210–370)
465
(348–590)
260
(194–331)
Australasia 2
(2–3)
2
(2–3)
3
(2–4)
2
(2–3)
2
(1–2)
2
(1–2)
5
(4–6)
3
(2–4)
0
(0–0)
6
(4–8)
6
(5–8)
7
(5–9)
2
(1–2)
Caribbean 132
(83–195)
146 
(90–228)
284 
(198–415)
73
(43–111)
119
(80–175)
92
(50–146)
129
(81–194)
90
(53–140)
7
(4–11)
272
(168–419)
300
(163–480)
410
(276–612)
92
(50–146)
Central Asia 58
(47–72)
84
(69–100)
55 
(45–67)
52
(41–67)
64
(50–80)
81
(66–100)
107
(86–133)
67
(55–83)
0
(0–0)
174
(139–215)
114
(92–141)
199
(164–242)
81
(66–100)
Central Europe 24
(20–28)
15
(12–18)
12
(10–14)
11
(9–14)
9
(7–11)
11
(8–13)
17
(14–20)
13
(10–16)
0
(0–0)
24
(19–27)
40
(33–48)
38
(31–45)
11
(8–13)
Central Latin 
America
331 
(294–376)
478
(426–537)
563
(495–635)
196
(173–223)
227
(198–261)
215
(177–251)
446
(394–505)
486
(428–546)
1
(1–2)
513
(392–672)
1112
(917–1347)
1110
(858–1354)
215
(177–251)
Central sub-
Saharan Africa
2679
(2031–
3491)
2233
(1663–
3018)
1645 
(1215–
2197)
863
(652–
1106)
1386 
(1010–
1870)
2350 
(1664–
3154)
2831 
(2078–
3712)
1222
(823–
1629)
114
(62–
167)
4805
(3654–
6210)
1298
(815–
1876)
6902
(5184–
8723)
2350 
(1664–
3154)
East Asia 395
(324–467)
709
(578–854)
322
(260–385)
365
(292–443)
298
(246–356)
376
(305–458)
545
(446–643)
518
(414–614)
0
(0–0)
725
(503–976)
1780
(1369–2213)
654
(439–899)
376
(305–458)
Eastern Europe 66
(54–80)
50
(39–60)
34
(26–42)
46
(34–60)
26
(20–33)
39
(27–53)
93
(75–112)
78
(62–95)
0
(0–0)
192
(150–235)
44
(28–63)
159
(127–195)
39
(27–53)
Eastern sub-
Saharan Africa
10 142 
(8413–
12 152)
6276
(5228–
7707)
5286 
(4327–
6467)
2718 
(2248–
3261)
4908 
(3967–
5996)
4702 
(3732–
5807)
13 312 
(11 350–
15 591)
3976
(3237–
5126)
844 
(524–
1144)
13 429 
(11 038–
16 452)
9176
(7334–
11 319)
24 962 
(20 629–
30 208)
4702 
(3732–
5807)
High-income 
Asia Paciﬁ c
17
(13–22)
22
(17–29)
12
(9–17)
10
(7–13)
13
(9–18)
7
(5–10)
26
(20–35)
21
(16–27)
0
(0–0)
51
(37–68)
33
(24–48)
37
(24–50)
7
(5–10)
High-income 
North America
97
(76–122)
44
(33–57)
64
(48–83)
51
(31–78)
63
(49–78)
143
(112–178)
224
(176–280)
143
(112–178)
0
(0–0)
120
(72–176)
254
(180–341)
313
(224–411)
143
(112–178)
North Africa 
and Middle East
1130
(843–
1500)
1831
(1421–
2415)
1294 
(1008–
1713)
838
(632–
1095)
809
(610–
1084)
836
(556–
1206)
1300 
(996–
1741)
847
(616–
1171)
3
(2–5)
2129
(1620–
2907)
2692
(1950–
3638)
3249
(2384–
4402)
836
(556–
1206)
Oceania 212
(108–363)
244
(123–437)
136
(68–249)
117
(59–203)
102
(53–185)
180
(92–335)
212
(111–379)
116
(58–205)
2
(1–3)
297
(151–543)
583
(308–1035)
264
(129–484)
180
(92–335)
South Asia 12 074 
(9081–
15 883)
16 453 
(11 957–
22 330)
10 656 
(7805–
14 072)
7099 
(5425–
9206)
9382 
(6734–
12 841)
19 900 
(14 138–
27 257)
19 433 
(14 257–
26 136)
12 601 
(9303–
16 472)
26
(13–43)
21 202 
(15 555–
27 811)
23 518 
(17 274–
30 621)
43 207 
(32 787–
55 636)
19 900 
(14 138–
27 257)
Southeast Asia 2638
(1964–
3459)
2656 
(1968–
3460)
2388 
(1718–
3144)
1346
(941–
1855)
1460 
(1044–
1935)
2274 
(1672–
3009)
3217 
(2348–
4232)
2001 
(1498–
2654)
9
(5–14)
4007
(2980–
5262)
8039
(6154–
10 319)
3708
(2836–
4927)
2274 
(1672–
3009)
Southern 
Latin America
94
(77–115)
44
(35–54)
45
(36–56)
28
(20–37)
73
(59–88)
29
(22–36)
51
(41–61)
80
(66–98)
0
(0–1)
196
(151–246)
107
(73–150)
114
(69–158)
29
(22–36)
Southern sub-
Saharan Africa
718
(488–1026)
517
(360–714)
624
(428–868)
298
(197–437)
627
(430–914)
604
(376–914)
463
(313–662)
657
(435–942)
381
(217–563)
1059
(660–1542)
1014
(571–1662)
2221
(1471–3256)
604
(376–914)
Tropical 
Latin America
225 
(171–287)
196
(147–253)
341
(259–435)
69
(51–92)
249
(192–317)
272
(178–378)
279
(214–356)
332
(253–426)
1
(1–2)
295
(191–418)
544
(349–776)
858
(623–1158)
272
(178–378)
Western Europe 55
(45–62)
35
(29–41)
34
(28–39)
23
(19–27)
24
(20–29)
23
(18–28)
60
(50–68)
34
(28–40)
0
(0–0)
65
(52–78)
89
(74–104)
112
(92–132)
23
(18–28)
Western sub-
Saharan Africa
12 436 
(10 015–
15 401)
11 990 
(9449–
15 320)
5301 
(4139–
6773)
4521 
(3382–
5992)
3749
(2745–
4945)
11 114 
(8229–
14 535)
13 239 
(10 539–
16 609)
7687 
(5894–
9976)
680 
(372–
1039)
11 460 
(8923–
14 807)
13 795 
(10 460–
18 323)
34 489 
(27 764–
42 248)
11 114 
(8229–
14 535)
*Intrapartum and immediate postpartum. †Subacute and delayed postpartum.
Table 2: Global and regional maternal deaths in 2013, by cause and timing 
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In 2013, 16 countries had MMRs of between 500 and 
1000: Afghanistan, Cameroon, Central African Republic, 
Chad, Côte d’Ivoire, Djibouti, Eritrea, Guinea, Guinea-
Bissau, Liberia, Lesotho, Mauritania, Papua New Guinea, 
Sierra Leone, South Sudan, and Zimbabwe (ﬁ gure 7, 
table 1). 15 countries had MMRs of less than 5: Andorra, 
Figure 6: Causes of maternal death
(A) Mean proportion (left) and total number (right) of maternal deaths due to diﬀ erent causes in 1990 and 2013. Error bars show 95% uncertainty intervals. 
(B) Proportion of maternal deaths due to diﬀ erent causes in 2013, by region. 
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Figure 8: Annualised rate of change in maternal mortality ratio in 1990–2003 and 2003–13
Countries are grouped by Global Burden of Disease super-region. Countries are labelled when at or near the MDG5 achievement rate, or if they had large increases in 
either period. MDG=Millennium Development Goal. RO U=Romania. POL=Poland. MDV=Maldives. MAR=Morocco. ALB=Albania. CZE=Czech Republic. ARE=United 
Arab Emirates. EST=Estonia. LBN=Lebanon. LVA=Latvia. CHN=China. LTU=Lithuania. HUN=Hungary. SLV=El Salvador. BLR=Belarus. GRC=Greece. RWA=Rwanda. 
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Figure 7: Maternal mortality ratio in 2013
ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. Isl=Islands. FSM=Federated States of Micronesia. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste.
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Australia, Austria, Denmark, Finland, Iceland, Ireland, 
Israel, Italy, Malta, Norway, Poland, Singapore, Sweden, 
and Switzerland (table 1). Some countries had noticeably 
higher MMRs than neighbouring countries did 
(ﬁ gure 7). In the Caribbean, only Guyana and Haiti had 
MMRs of more than 100 in 2013 (ﬁ gure 7, table 1). 
Similarly, in South America, only Bolivia had an MMR 
of more than 100 (ﬁ gure 7, table 1). Afghanistan had the 
highest MMR in south Asia, Yemen had the highest 
MMR in north Africa and the Middle East, and Papua 
New Guinea had the largest value in southeast Asia and 
Oceania in 2013 (ﬁ gure 7, table 1). The MMR in China 
was 17·2 (95% UI 14·0–20·3) compared with 18·5 
(14·8–22·9) in the USA. In sub-Saharan Africa, 
Mauritius, Seychelles, Namibia, Swaziland, Cape Verde, 
and São Tomé and Príncipe have MMRs of less than 150 
(ﬁ gure 7, table 1).
137 countries had higher annualised rates of change in 
MMR between 2003 and 2013 than between 1990 and 
2003 (ﬁ gure 8). Nevertheless, only 40 countries have 
achieved the MDG 5 decrease of 5·5% per year in either 
time interval (ﬁ gure 8). From 1990 to 2013, Albania, 
United Arab Emirates, Bosnia and Herzegovina, Belarus, 
China, Estonia, Lebanon, Lithuania, Latvia, Morocco, 
Maldives, Mongolia, Oman, Poland, Romania, and 
Russia had reductions of greater than 5·5% (table 1). 
These countries—which represent 5·1% of all developing 
nations—are likely to achieve the MDG 5 target of a 
reduction in the MMR of three-quarters. 30 countries 
had annual reductions in the MMR of MDG 5 pace or 
better from 2003 to 2013, eight of which were in sub-
Saharan Africa (Botswana, Burundi, Kenya, Malawi, 
Namibia, Rwanda, South Africa, and Swaziland) and ten 
in central and eastern Europe (Albania, Belarus, Bosnia 
and Herzegovina, Bulgaria, Estonia, Latvia, Lithuania, 
Poland, Romania, and Russia; table 1). Between 2003 and 
2013, eight countries had annualised rates of change of 
more than 8%: Belarus, Botswana, China, Estonia, Latvia, 
Lebanon, Lithuania, and Malawi (ﬁ gure 8, table 1). From 
1990 to 2003, MMR increased in 50 countries, 27 of 
which were in sub-Saharan Africa (table 1). Between 2003 
and 2013, only eight countries had increases: Afghanistan, 
Belize, El Salvador, Guinea-Bissau, Greece, Seychelles, 
South Sudan, and the USA (ﬁ gure 8, table 1).
In our fairly optimistic forecast scenario for 2030, we 
would expect 184 100 (95% UI 133 600–244 700) maternal 
deaths worldwide in 2030. 53 countries—all of which are 
in sub-Saharan Africa, except for Afghanistan, 
Bangladesh, Bhutan, Bolivia, Haiti, India, Indonesia, 
Laos, Myanmar, Nepal, Pakistan, Papua New Guinea, 
Solomon Islands, and Yemen—will still have MMRs of 
more than 100 (ﬁ gure 9). Despite accelerated reductions 
in many countries, our simple forecasts suggest that in 
2030, 74 countries are likely to still have a MMR of more 
Figure 9: Projected maternal mortality ratio in 2030
ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. Isl=Islands. FSM=Federated States of Micronesia. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste.
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than 50, and 89 countries will have MMRs of less than 30, 
compared with 72 countries in 2013.
Discussion
On the basis of recent data and a reﬁ ned understanding 
of the association between HIV and maternal mortality, 
we have shown that worldwide maternal mortality has 
decreased by 1·3% per year since 1990. Despite 
reductions in the number of maternal deaths—from 
about 376 000 in 1990 to about 293 000 in 2013—only 
16 countries, seven of which are developing countries, 
are expected to achieve the MDG 5 target of a 75% 
reduction in the MMR by 2015. We noted two diﬀ erent 
patterns in developing countries: sustained substantial 
decreases in most of Asia and Latin America, and 
stagnation or increases from 1990 to 2003 in sub-Saharan 
Africa and Oceania. Increases in some high-income 
countries such as the USA are a deviation from the 
general trend downwards in developed countries. 
However, the substantial acceleration in the decreases 
since 2003—especially in sub-Saharan Africa—provides 
hope that more countries can achieve rapid and sustained 
reductions.
Ambitious calls for progress in maternal mortality in 
the next 15–20 years and reductions in MMRs to less 
than 30 in all countries have been deemed ﬁ nancially and 
technically feasible.48 Our ﬁ nding that rates of change in 
maternal mortality in some developing countries have 
exceeded 8% in the past decade (eg, in China) lends 
support to ambitious aspirational goals. However, on the 
accelerated trajectory from 2003 to 2013, MMRs will still 
be high in several countries in west and central Africa, 
and in the Horn of Africa. Unsurprisingly, projections for 
child mortality in 2030 are also high in these areas of the 
world. A focus on levels of maternal mortality equivalent 
to those in high-income nations in all countries will need 
special policy attention, national action, and global 
investment in the countries that are predicted to be left 
far behind a grand convergence. Many of the countries in 
central and west Africa that will present the greatest 
challenge to achievement of low MMRs have historically 
received less development assistance for health than have 
other low-income countries.49 Although development 
assistance for maternal, newborn, and child health has 
been increasing at a pace faster than that for most 
thematic areas, excluding HIV, especially since 2009, 
increases in central and west Africa have not been as 
large as in other regions. A new focus on these countries 
will probably need action by multilateral, bilateral, and 
private global health funders, and shifts in the historical 
allocation of funds across low-income countries.
The drivers of improvement (or lack thereof) in 
underlying causes of maternal deaths have important 
clinical, public health, and policy implications. Maternal 
mortality has been successfully reduced in many 
countries. Although the absolute numbers of deaths due 
to abortion, maternal haemorrhage, and hypertensive 
disorders of pregnancy have decreased in real terms, 
these causes remain important, collectively accounting 
for nearly 50% of all deaths. Continued promotion of 
policies to reduce anaemia and malnutrition, prevent 
malaria in pregnancy, provide calcium and micronutrient 
supplementation, encourage skilled birth attendance and 
in-facility delivery, discourage early motherhood, and 
reduce unsafe abortion should lead to sustained 
dividends.50–52 Such focus should be expected to reduce 
the risk of life-threatening complications of pregnancy, 
but the complications will not be eliminated altogether. 
Increased coverage of skilled birth attendance and 
delivery in facilities properly resourced for emergency 
obstetric care is essential for prevention of these deaths.
Health-system re-engineering is necessary to begin 
preparations for the new challenges that lie ahead. The 
increasing relative importance of other direct, indirect, 
and late maternal causes of death is consistent with global 
epidemiological transition, and suggests that many health 
systems are inadequate to meet the needs of an increasing 
number of pregnant women with pre-existing conditions 
and high-risk pregnancies. The risks of sepsis-related 
deaths are known to be increased by the prevalence of 
obesity and diabetes in women of reproductive age.53 
Moreover, because of the inherent diﬃ  culty in diagnosis 
of maternal sepsis, the problem could be larger than we 
have estimated in countries with high overall maternal 
mortality. Therefore, prevention of sepsis will need not 
only a focus on medical management of comorbidities, 
but also improved sanitation and access to routine 
prophylactic antibiotics during caesarean section for 
facilities that intend to provide such a service, both of 
which have been shown to be eﬀ ective and cost-eﬀ ective 
strategies to reduce maternal death.54,55
Many diseases—eg, sickle-cell anaemia, obesity, diabetes, 
hypertension, and chronic kidney conditions—confer 
increased mortality risk during pregnancy. These indirect 
causes of maternal death are likely to continue increasing 
in importance where they are commonly encountered.56–60 
A focus on health-system strengthening will be needed to 
reduce the eﬀ ect of other direct causes of maternal death, 
because the most likely underlying aetiologies are 
complications of anaesthesia, embolism (air, amniotic 
ﬂ uid, and blood clot), and the less common but often fatal 
condition of peripartum cardiomyopathy.61–64 Health 
systems must begin to plan for these changes through 
increasing the size and training of the perioperative 
workforce and investment in family planning services, 
adequate infrastructural resources for facilities, and 
systems to identify and follow women who are at risk of 
life-threatening puerperial and postpartum complications.
In 2013, HIV accounted for 1·5% of maternal deaths in 
sub-Saharan Africa, rising to 6·2% in southern sub-
Saharan Africa. However, HIV infection is associated with 
the smallest number of deaths worldwide of any of the 
causes we examined. Increased ART coverage has led to 
reduced HIV-related mortality in sub-Saharan Africa and 
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has been associated with decreased mortality in HIV-
positive women during pregnancy.45,65 Nevertheless, the 
increase in maternal mortality during the mid-2000s in 
southern Africa is well in excess of the number of HIV-
associated maternal deaths. There are at least four possible 
explanations for this ﬁ nding. First, we could have 
underestimated the RR of death for a pregnant woman 
with HIV infection compared with a pregnant woman 
without HIV infection. Our meta-analysis results are 
consistent with previous studies, but the RR could be 
biased downwards if included studies are from areas with 
better care or access to ART.22,34 Second, we could have 
overestimated maternal mortality if the UNAIDS 
Spectrum estimates of HIV prevalence in pregnancy are 
underestimates. These values suggest that age-speciﬁ c 
fertility rates decrease by 24% in HIV-positive women 
compared with HIV-negative women when aged 
20–24 years, but fertility decreases by 56% by age 
45–49 years.66 Third, we assume the RR is generalisable 
across diﬀ erent levels of HIV prevalence in pregnant 
women, which might not be true. Fourth, the HIV 
epidemic could be diverting resources from maternal care 
because of a huge demand for care. Although this 
situation is theoretically possible, several studies and 
reports have not shown this relation; indeed, there could 
be synergies between ART scale-up and clinic and hospital 
productivity.67 Perhaps the most important ﬁ nding is that 
with the scale-up of ART, MMR seems to decrease rapidly 
(eg, in Malawi).68
In our study, we have not tested the association between 
development assistance for maternal health programmes 
and MMR. However, accelerated decreases occurred in 
106 of 138 developing countries in 2003—3 years after 
the Millennium Declaration—coinciding with the scale-
up of development assistance for maternal and child 
health programmes.49 Rigorous testing of the hypothesis 
that global priority setting and investments in maternal 
health programmes have had an important role in the 
acceleration of progress is needed. This research is 
important because it could strengthen the basis on which 
post-2015 requests for funding of continued expansion of 
maternal health services are made. Because we have 
reported much slower rates of change than the UN has,6 
the importance of establishing the case for continued 
investment in maternal health programmes is even 
greater; ambitious goals for regions such as sub-Saharan 
Africa will probably need major investments.
We compared our estimates of maternal mortality 
with those from the GBD 2010 and the 2012 UN 
estimates.6 The correlation between our MMR estimates 
and those of GBD 2010 for 1990 was 0·96, and for 2010 
was 0·89. The correlation ﬁ gures with the UN analysis 
for the same two periods were 0·88 and 0·85. Perhaps 
the most notable diﬀ erence between the UN 2012 
analysis and ours is the number of maternal deaths in 
1990: 543 000 compared with 376 000. The diﬀ erence in 
numbers for 2010 is smaller: 287 000 deaths compared 
with 317 300. The much higher number from the UN 
for 1990 raises the estimated annualised rate of change 
in the MMR from 1990 to 2010 substantially, to –3·1% 
per year compared with –1·1% per year in our study. 
One of the most important diﬀ erences between our 
assessment and the UN’s seems to be related to the 
WHO estimates of reproductive-age mortality in some 
Figure 10: Comparison of all-cause reproductive-age mortality envelopes between 1990 and 2010
WPP=World Population Prospects. GBD=Global Burden of Disease Study.
1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010
100 000
200 000
300 000
400 000
500 000
600 000
To
ta
l n
um
be
r o
f r
ep
ro
du
ct
iv
e-
ag
e d
ea
th
s
Year
Western sub-Saharan Africa
1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010
0
50 000
100 000
150 000
250 000
400 000
350 000
300 000
200 000
To
ta
l n
um
be
r o
f r
ep
ro
du
ct
iv
e-
ag
e d
ea
th
s
Year
Southeast Asia
WHO 2010
WPP 2008
WPP 2010
WPP 2012
Lozano et al 2011
GBD 2010
GBD 2013
Carattere Scientiﬁ co Burlo 
Garofolo, Trieste, Italy 
(L Monasta DSc, L Ronfani PhD); 
Bureau of International Health 
Cooperation, Manila City, 
Philippines 
(J de la Cruz Monis MSc); 
University of North Texas, 
Denton, TX, USA 
(Prof A R Moore PhD); Iran 
University of Medical Sciences, 
Department of Community 
Medicine, Tehran, Iran 
(M Moradi-Lakeh); National 
Centre for Child Health and 
Development, Setagaya, Tokyo, 
Japan (R Mori PhD); 
Philipps-University Marburg, 
Marburg, Germany 
(Prof U O Mueller PhD, 
R Westerman PhD); Tokyo 
Medical and Dental University, 
Tokyo, Japan 
(M Mukaigawara MD); 
International Centre for 
Diarrhoeal Diseases Research, 
Dhaka, Bangladesh 
(A Naheed PhD); University of 
KwaZulu-Natal, Durban, South 
Africa (Prof K S Naidoo PhD); 
Ministry of Health Fiji, Suva, Fiji 
(D Nand MPH); Suraj Eye 
Institute, Nagpur, India 
(Prof V Nangia MD); School of 
Public Health, City University of 
New York, New York, NY, USA 
(D Nash PhD); Faculty of 
Medicine, Fez, Morocco 
(Prof C Nejjari PhD); National 
Institute of Diabetes and 
Digestive and Kidney Diseases, 
Phoenix, AZ, USA 
(R G Nelson PhD); Norwegian 
Centre for Addiction Research 
(SERAF), University of Oslo, Oslo, 
Norway (S P Neupane MBBS); 
Kenya Medical Research Institute 
Wellcome Trust Programme, 
Kiliﬁ , Kenya 
(Prof C R Newton MD); Centre for 
Research in Environmental 
Epidemiology (CREAL), 
Barcelona, Spain 
(M J Nieuwenhuijsen PhD); 
University of Bergen, Bergen, 
Norway (Prof O F Norheim PhD); 
Kyung Hee Unversity, Seoul, 
South Korea (I-H Oh PhD); Teikyo 
University School of Medicine, 
Tokyo, Japan (Prof T Ohkubo MD); 
Centre for Healthy Start 
Initiative, Lagos, Nigeria 
(B O Olusanya PhD); Lira District 
Local Government, Lira 
Municipal Council, Lira, Uganda 
(J N Opio MPH); Toxicology Unit, 
Faculty of Pharmacy, University 
of Port Harcourt, Port Harcourt, 
Nigeria (Prof O E Orisakwe PhD); 
Christian Medical College 
Ludhiana, Ludhiana, India
Articles
www.thelancet.com   Vol 384   September 13, 2014 1001
(J D Pandian MD); 
Sungkyunkwan University 
School of Medicine, Suwon, 
South Korea (Prof J-H Park MPH); 
Universidad de Cartagena, 
Cartagena, Colombia 
(A J Paternina Caicedo MSc); 
University of Calgary, Calgary, 
AB, Canada (Prof S B Patten PhD); 
All India Institute of Medical 
Sciences (AIIMS), New Delhi, 
India (Prof V K Paul MD); WHO, 
Waigani, Papua New Guinea 
(B I Pavlin MD); London School of 
Hygiene & Tropical Medicine, 
London, UK (Prof N Pearce PhD); 
3B’s Research Group in 
Biomaterials, Biodegradables 
and Biomimetics, University of  
Minho, Headquarters of the 
European Institute of Excellence 
on Tissue Engineering and  
Regenerative Medicine, and 
ICVS/3B’s PT Government  
Associate Laboratory, Braga 
Portugal (Prof D M Pereira PhD); 
Flinders University, Adelaide, SA, 
Australia (Prof K Pesudovs PhD); 
Centre for Applied Biostatistics, 
Sahlgrenska Academy, 
University of Gothenburg, 
Sweden (Prof M Petzold PhD); 
McMaster University, Hamilton, 
ON, Canada (D Poenaru MD); 
Erasmus Medical Center, 
regions with high fractions of reproductive-age 
mortality due to maternal causes. These estimates are 
substantially higher than the GBD 2013 estimates for 
west Africa, north Africa and the Middle East, and 
southeast Asia in 1990, ranging from 7% higher in 
Ghana to 58% higher in Nigeria. The diﬀ erences 
between estimates of reproductive-age mortality in 
western sub-Saharan Africa and southeast Asia are 
large (ﬁ gure 10). In some cases, the most recent UN 
Population Division estimates (World Population 
Prospects 2012) converge towards the GBD estimates, 
although WHO estimates are substantially higher 
(ﬁ gure 10). The UN Population Division and WHO 
almost exclusively predict levels of adult mortality in 
west Africa on the basis of child mortality, whereas we 
make substantial use of survey and census data from 
the region in our GBD analysis.69 The reasons for the 
changes between successive revisions of maternal 
mortality estimates depend on the country, but are 
driven both by new data for levels of reproductive-age 
mortality and maternal causes or the fraction of deaths 
that are related to pregnancy.
Our study, which brings together a wide array of data 
sources for the levels, causes, and timing of maternal 
deaths for many countries, has important limitations. 
First, although ICD-coded vital registration systems 
have clear rules for assignment of causes of death, we 
used census and survey data for the fraction of deaths to 
distinguish explicitly between deaths caused by 
pregnancy (maternal deaths) and those that were 
incidental (pregnancy-related deaths). We made 
adjustments for incidental deaths related to HIV, but 
have not made similar adjustments for other types of 
incidental deaths due to causes such as injuries. 
Studies70,71 suggest that deaths due to injury are less 
common in non-pregnant women than in pregnant 
women of the same age, but they do occur in both 
groups, which leads to a bias upwards in our assessment. 
That bias must be tempered with the potential bias that 
sibling and household reports of pregnancy-related 
deaths could lead to selective under-reporting of 
abortion-related deaths.72 Second, uncertainty in the 
estimates of maternal death in many countries is 
substantial.73 Within the same country, sources can diﬀ er 
widely. For example, we used many diﬀ erent types of 
sources in India: in rural regions, data are largely from 
the Survey of Causes of Death-Rural, the Sample 
Registration System, and verbal autopsy studies, whereas 
Medical Certiﬁ cation of Causes of Death covers largely 
urban populations.4
Third, there is still no deﬁ nitive way to estimate the 
interaction of HIV and pregnancy in death. Only 
21 studies were available for estimation of the excess risk 
of death during pregnancy in women with HIV. Only 
two studies44,45 inform the excess risk of death during 
pregnancy in women with HIV. These two studies 
provide widely divergent ﬁ ndings and could reﬂ ect the 
complex interaction between ART (and the associated 
greater care received by women taking it) and pregnancy 
as much as the eﬀ ect of pregnancy on the progression of 
HIV. As such data continue to be developed and because 
of the important implications for policy making, we will 
continue to work to ﬁ nd new data sources, improve data 
quality, and incorporate updated methods as necessary 
to continue providing updates for global, regional, and 
national maternal mortality.
Fourth, because of sparse data, we could not quantify 
the contributions of other infections, such as inﬂ uenza 
(eg, H1N1), malaria, tuberculosis, and hepatitis, to 
maternal mortality at the population level.74 Fifth, our 
method of estimating the detailed causes of maternal 
death used all available data, but such speciﬁ c data are 
not available for many countries, or, if they are available, 
are coarse with respect to age. Therefore, we might have 
underestimated the true extent of the interplay between 
cause and age in maternal mortality and diﬀ erences 
between countries in the same region.
Sixth, we have estimated UIs for each component of the 
analysis. CODEm provides conﬁ rmation that the UIs for 
the maternal mortality model have a data coverage of 
97·9%, so they could be slightly overestimated. Finally, 
our estimates of maternal mortality are aﬀ ected by 
estimates in each age group of other causes of death 
developed for the GBD 2013 because of the requirement 
that cause-speciﬁ c mortality must sum to all-cause 
Panel: Research in context
Our analysis continues a body of analytical work into levels and trends in maternal 
mortality that began with Hogan and colleagues’ report4 and was followed by that by 
Lozano and colleagues5 and the Global Burden of Disease Study 2010 (GBD 2010).16 With 
each subsequent study, there have been important advances in the data available for 
analysis and the methods of analysis. Lozano and colleagues5 moved from one preferred 
regression model, as used by Hogan and colleagues and the UN measurement eﬀ orts,6,20 to 
an ensemble of multiple models developed through rigorous out-of-sample predictive 
validity testing. The maternal mortality analysis included in GBD 2010 extended the 
analysis in two important ways: maternal mortality was assessed with all other causes of 
death subject to the constraint that sum of individual causes of death equalled the 
demographic assessment of all-cause mortality in each age group of reproductive-age 
women, and it included estimates of the major causes of maternal mortality. In our study, 
in addition to 2421 site-years of new data, several important methodological innovations 
improve the estimation of maternal mortality. First, we have analysed sibling history data 
for the fraction of reproductive-age deaths that are related to pregnancy by calendar year 
for each 5-year age group of mothers, pooling data from several surveys when events for 
the same calendar year were recorded. Second, we have substantially revised the approach 
to understand the eﬀ ect of HIV on maternal mortality. We did a systematic review and 
used relative risks from cohort studies to accurately assign a fairly small fraction of HIV-
related deaths during pregnancy or the puerperium to be maternal deaths. Third, we have 
quantiﬁ ed other direct maternal causes, indirect maternal causes, and late maternal death 
for the ﬁ rst time. Fourth, we have analysed previous reports and other sources about the 
timing of maternal deaths to provide guidance on when most deaths occur. Our data and 
improved methods have led to a diﬀ erent understanding of the evolution of global 
maternal deaths with important implications for target setting in the post-MDG era. 
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mortality. Errors in the estimates for other causes of death 
could bias upwards or downwards our assessments of 
maternal mortality.
An important part of improved measurement in the 
future is a recommendation that surveillance of late 
maternal mortality (>42 days but <1 year) be included in 
surveys and censuses. With the assumption that maternal 
mortality will continue to decrease, severe maternal 
morbidity or so-called near miss cases are likely to 
increase, some of which might be expected to lead to 
increased late maternal death.54 Perhaps more 
importantly for some regions, HIV has been described 
by some as being a risk factor for late maternal death. If 
this description is true, these deaths might not be 
captured appropriately, because neither reproductive 
health surveys nor demographic and health surveys 
quantify late maternal death. In view of the major 
dependency on sibling histories and the recall of 
pregnancy-related deaths in household surveys, major 
changes would be necessary to track late maternal deaths 
through these instruments.
Measurement of maternal mortality remains 
challenging (panel). It depends both on robust 
demographic assessment of reproductive-age mortality 
rates and data for the fraction of deaths in each age 
group that are maternal or related to pregnancy. Changes 
between systematic analyses in the levels and trends in 
maternal mortality are larger than for child mortality. As 
a result, users of any assessment of maternal mortality 
need to recognise that assessments could change as new 
data are identiﬁ ed or obtained. Despite continuing 
measurement challenges, there are strong reasons to 
continue a global focus on reductions in maternal death 
in the next 15–20 years. An important adjunct to both the 
framing of new goals and mobilisation of action for 
them will be regular updates about the evidence in the 
trends for maternal mortality by age, cause, and timing. 
We believe that it is this evidence that should fuel and 
inspire debates and policies to reduce maternal deaths. 
We believe the evidence is convincing that decreases in 
the MMR have accelerated in several countries since 
2003. These accelerations should be carefully studied to 
provide qualitative insights into what has worked in 
diﬀ erent settings. As new global targets for maternal 
mortality are developed, it will be important to take 
lessons from these insights, but also begin planning for 
the evolving health and health-care needs of women of 
reproductive age. Achievement (or not) of arbitrary goals 
established without proper regard to the distribution of 
rates of change prevailing at the time is a political 
construct that obscures knowledge and praise for the 
substantial progress that has been made to reduce 
maternal mortality in the past decade. Furthermore, 
accelerated decreases in maternal mortality will be more 
likely if the evidence from policy responses in these 
countries is widely and eﬀ ectively disseminated and 
implemented.
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